<?xml version="1.0" encoding="UTF-8"?>
<hmdb xmlns="http://www.hmdb.ca">
<metabolite>
  <version>5.0</version>
  <creation_date>2005-11-16 15:48:42 UTC</creation_date>
  <update_date>2021-10-13 17:34:04 UTC</update_date>
  <accession>HMDB0000001</accession>
  <status>quantified</status>
  <secondary_accessions>
    <accession>HMDB00001</accession>
    <accession>HMDB0004935</accession>
    <accession>HMDB0006703</accession>
    <accession>HMDB0006704</accession>
    <accession>HMDB04935</accession>
    <accession>HMDB06703</accession>
    <accession>HMDB06704</accession>
  </secondary_accessions>
  <name>1-Methylhistidine</name>
  <description>1-Methylhistidine, also known as 1-MHis or 1MH, belongs to the class of organic compounds known as histidine and derivatives. 1MH is also classified as a methylamino acid. Methylamino acids are primarily proteogenic amino acids (found in proteins) which have been methylated (in situ) on their side chains by various methyltransferase enzymes. Histidine can be methylated at either the N1 or N3 position of its imidazole ring, yielding the isomers 1-methylhistidine (1MH; also referred to as pi-methylhistidine) or 3-methylhistidine (3MH; tau-methylhistidine), respectively. There is considerable confusion with regard to the nomenclature of the methylated nitrogen atoms on the imidazole ring of histidine and other histidine-containing peptides such as anserine. In particular, older literature (mostly prior to the year 2000) designated anserine (Npi methylated) as beta-alanyl-N1-methyl-histidine, whereas according to standard IUPAC nomenclature, anserine is correctly named as beta-alanyl-N3-methyl-histidine. As a result, many papers published prior to the year 2000 incorrectly identified 1MH as a specific marker for dietary consumption or various pathophysiological effects when they really were referring to 3MH (PMID: 24137022).  Recent discoveries have shown that 1MH is produced in essentially all mammals (and other vertebrates) via the enzyme known as METTL9 (PMID: 33563959). METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mammalian proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where "x" is a small amino acid. This HxH motif is found in a number of abundant mammalian proteins such as ARMC6, S100A9, and NDUFB3 (PMID: 33563959). Because of its abundance in many muscle-related proteins, 1MH has been found to be a good biomarker for the consumption of meat (PMID: 21527577). Dietary studies have shown that poultry consumption (p-trend = 0.0006) and chicken consumption (p-trend = 0.0003) are associated with increased levels of 1MH in human plasma (PMID: 30018457). The consumption of fish, especially salmon and cod, has also been shown to increase the levels of 1MH in serum and urine (PMID: 31401679). As a general rule, urinary 1MH is associated with white meat intake (p&lt; 0.001), whereas urinary 3MH is associated with red meat intake (p&lt; 0.001) (PMID: 34091671).</description>
  <synonyms>
    <synonym>(2S)-2-Amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</synonym>
    <synonym>Pi-methylhistidine</synonym>
    <synonym>(2S)-2-Amino-3-(1-methyl-1H-imidazol-4-yl)propanoate</synonym>
    <synonym>1 Methylhistidine</synonym>
    <synonym>1-Methyl histidine</synonym>
    <synonym>1-Methyl-histidine</synonym>
    <synonym>1-Methyl-L-histidine</synonym>
    <synonym>1-MHis</synonym>
    <synonym>1-N-Methyl-L-histidine</synonym>
    <synonym>L-1-Methylhistidine</synonym>
    <synonym>N1-Methyl-L-histidine</synonym>
    <synonym>1-Methylhistidine dihydrochloride</synonym>
    <synonym>1-Methylhistidine</synonym>
  </synonyms>
  <chemical_formula>C7H11N3O2</chemical_formula>
  <average_molecular_weight>169.1811</average_molecular_weight>
  <monisotopic_molecular_weight>169.085126611</monisotopic_molecular_weight>
  <iupac_name>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</iupac_name>
  <traditional_iupac>1 methylhistidine</traditional_iupac>
  <cas_registry_number>332-80-9</cas_registry_number>
  <smiles>CN1C=NC(C[C@H](N)C(O)=O)=C1</smiles>
  <inchi>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</inchi>
  <inchikey>BRMWTNUJHUMWMS-LURJTMIESA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct_parent>Histidine and derivatives</direct_parent>
    <kingdom>Organic compounds</kingdom>
    <super_class>Organic acids and derivatives</super_class>
    <class>Carboxylic acids and derivatives</class>
    <sub_class>Amino acids, peptides, and analogues</sub_class>
    <molecular_framework>Aromatic heteromonocyclic compounds</molecular_framework>
    <alternative_parents>
      <alternative_parent>Amino acids</alternative_parent>
      <alternative_parent>Aralkylamines</alternative_parent>
      <alternative_parent>Azacyclic compounds</alternative_parent>
      <alternative_parent>Carbonyl compounds</alternative_parent>
      <alternative_parent>Carboxylic acids</alternative_parent>
      <alternative_parent>Heteroaromatic compounds</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>Imidazolyl carboxylic acids and derivatives</alternative_parent>
      <alternative_parent>L-alpha-amino acids</alternative_parent>
      <alternative_parent>Monoalkylamines</alternative_parent>
      <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
      <alternative_parent>N-substituted imidazoles</alternative_parent>
      <alternative_parent>Organic oxides</alternative_parent>
      <alternative_parent>Organopnictogen compounds</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>Alpha-amino acid</substituent>
      <substituent>Amine</substituent>
      <substituent>Amino acid</substituent>
      <substituent>Aralkylamine</substituent>
      <substituent>Aromatic heteromonocyclic compound</substituent>
      <substituent>Azacycle</substituent>
      <substituent>Azole</substituent>
      <substituent>Carbonyl group</substituent>
      <substituent>Carboxylic acid</substituent>
      <substituent>Heteroaromatic compound</substituent>
      <substituent>Histidine or derivatives</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>Imidazole</substituent>
      <substituent>Imidazolyl carboxylic acid derivative</substituent>
      <substituent>L-alpha-amino acid</substituent>
      <substituent>Monocarboxylic acid or derivatives</substituent>
      <substituent>N-substituted imidazole</substituent>
      <substituent>Organic nitrogen compound</substituent>
      <substituent>Organic oxide</substituent>
      <substituent>Organic oxygen compound</substituent>
      <substituent>Organoheterocyclic compound</substituent>
      <substituent>Organonitrogen compound</substituent>
      <substituent>Organooxygen compound</substituent>
      <substituent>Organopnictogen compound</substituent>
      <substituent>Primary aliphatic amine</substituent>
      <substituent>Primary amine</substituent>
    </substituents>
    <external_descriptors>
      <external_descriptor>L-histidine derivative</external_descriptor>
      <external_descriptor>non-proteinogenic L-alpha-amino acid</external_descriptor>
    </external_descriptors>
  </taxonomy>
  <ontology>
    <root>
      <term>Physiological effect</term>
      <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Health effect</term>
          <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
          <parent_id>7693</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Health condition</term>
              <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Kidney disease</term>
                  <definition>A urinary system disease that is located in the kidney. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Renal disease</synonym>
                    <synonym>Nephropathy</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Diabetes mellitus type 2</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Non-insulin-dependent diabetes mellitus</synonym>
                    <synonym>Niddm</synonym>
                    <synonym>Adult-onset diabetes</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Metabolism and nutrition disorders</term>
                  <definition>A group of disorders, inherited or not, that result in a metabolic malfunction.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Obesity</term>
                      <definition>A disorder characterized by having a high amount of body fat. (nci ctcae).</definition>
                      <parent_id>7708</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Disposition</term>
      <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Source</term>
          <definition>Natural or synthetic origin of a chemical.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Endogenous</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological location</term>
          <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Tissue and substructures</term>
              <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Muscle</term>
                  <definition>A fibrous soft tissue with the ability to contract to produce force and motion. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Skeletal muscle</term>
                  <definition>Striated muscles that are under voluntary control of the organism. they are connected at either or both ends to a bone and are utilized for locomotion and other movements. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Striated muscle</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Placenta</term>
                  <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biofluid and excreta</term>
              <definition>A liquid, semi-solid or solid material originating in the body.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Saliva</term>
                  <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Feces</term>
                  <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fecal</synonym>
                    <synonym>Stool</synonym>
                    <synonym>Faecal</synonym>
                    <synonym>Faeces</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Urine</term>
                  <definition>Excretion in liquid state processed by the kidney.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Blood</term>
                  <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cerebrospinal fluid</term>
                  <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Csf</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Subcellular</term>
              <definition>An anatomical organizational level including a component within a biological cell .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cytoplasm</term>
                  <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Cytoplasma</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Process</term>
      <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Naturally occurring process</term>
          <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
          <parent_id>7659</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biological process</term>
              <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
              <parent_id>7660</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biochemical pathway</term>
                  <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                  <parent_id>7661</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Histidine Metabolism</term>
                      <definition> after reaching several years of age, humans begin to synthesize it (most likely in the intestinal micrflora) and it thus becomes a non-essential amino acid. humans can obtain histidine through the breakdown of carnosine (a dipeptide containing histidine and beta-alanine) via the action of carnosine dipeptidase.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Role</term>
      <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Industrial application</term>
          <definition>The assumed function of a chemical utilized by human.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Pharmaceutical industry</term>
              <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
              <parent_id>7678</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical</term>
                  <definition/>
                  <parent_id>7679</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
  </ontology>
  <state>Solid</state>
  <experimental_properties>
    <property>
      <kind>water_solubility</kind>
      <value>200 g/kg</value>
      <source>http://download.cappchem.com/data/Properties-of-Amino-Acids.pdf</source>
    </property>
    <property>
      <kind>melting_point</kind>
      <value>249 °C</value>
      <source>http://download.cappchem.com/data/Properties-of-Amino-Acids.pdf</source>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>-2.95</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>-1.39</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>6.93 g/L</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>-3.1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>1.96</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>9.25</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>169.1811</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>169.085126611</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>CN1C=NC(C[C@H](N)C(O)=O)=C1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C7H11N3O2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>BRMWTNUJHUMWMS-LURJTMIESA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>81.14</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>42.39</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>17.11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <spectra>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>915</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1022</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5292</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5293</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5294</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5295</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5296</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5297</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5298</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5299</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5300</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5301</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5302</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5303</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5304</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5305</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5306</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5307</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5308</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5309</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5310</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5311</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1469</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>1755</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>7663</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30940</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30941</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>37237</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>166679</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>255159</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>255160</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>255161</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>275100</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>275101</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>275102</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2346413</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2346414</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2346415</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2593057</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2593058</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2593059</spectrum_id>
    </spectrum>
  </spectra>
  <biological_properties>
    <cellular_locations>
      <cellular>Cytoplasm</cellular>
    </cellular_locations>
    <biospecimen_locations>
      <biospecimen>Blood</biospecimen>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <biospecimen>Feces</biospecimen>
      <biospecimen>Saliva</biospecimen>
      <biospecimen>Urine</biospecimen>
    </biospecimen_locations>
    <tissue_locations>
      <tissue>Placenta</tissue>
      <tissue>Skeletal Muscle</tissue>
    </tissue_locations>
    <pathways>
      <pathway>
        <name>1-Methylhistidine Metabolism</name>
        <smpdb_id>SMP0124716</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Histidine metabolism</name>
        <smpdb_id>SMP00044</smpdb_id>
        <kegg_map_id>map00340</kegg_map_id>
      </pathway>
      <pathway>
        <name>Histidinemia</name>
        <smpdb_id>SMP00191</smpdb_id>
        <kegg_map_id/>
      </pathway>
    </pathways>
  </biological_properties>
  <normal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gonzalez-Dominguez R, Jauregui O, Queipo-Ortuno MI, Andres-Lacueva C: Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform. Anal Chem. 2020 Oct 20;92(20):13767-13775. doi: 10.1021/acs.analchem.0c02008. Epub 2020 Sep 30.</reference_text>
          <pubmed_id>32966057</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>7.7 +/- 1.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
          <pubmed_id>7061274</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>14.4 +/- 2.3</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
          <pubmed_id>7061274</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>19.6 +/- 2.6</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
          <pubmed_id>7061274</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>12.7 +/- 2.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
          <pubmed_id>7061274</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>20.2 +/- 4.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
          <pubmed_id>7061274</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>9.1 +/- 7.2</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 85-97. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4.0 +/- 8.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 85-97. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>4.0 +/- 1.74</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By CIL LC−MS </comment>
      <references>
        <reference>
          <reference_text>Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, Lu Y, Su X, Xie Q, Li L, Li L: Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 2015 Jan 20;87(2):829-36. doi: 10.1021/ac503619q. Epub 2014 Dec 25.</reference_text>
          <pubmed_id>25486321</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
      <references>
        <reference>
          <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
          <pubmed_id>29808030</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
          <pubmed_id>27543620</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>26.34</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Vranic L, Granic P, Rajic Z: Basic amino acid in the pathogenesis of caries. Acta Stomatol Croat. 1991;25(2):71-6.</reference_text>
          <pubmed_id>1819935</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.15-162.32</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>10-17 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age/>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J: SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012 Nov;404(8):2349-61. doi: 10.1007/s00216-012-6339-2. Epub  2012 Aug 31.</reference_text>
          <pubmed_id>22932811</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.36-175.22</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adolescent (13-18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>17.74-153.77</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>David F. Putnam Composition and Concentrative Properties of Human Urine. NASA Contractor Report. July 1971</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>8.3 (2.4-28.4)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>urine by NMR</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.60-151.46</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.9 +/- 19.5 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>46.0833 +/- 53.432</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Blacks - Omnivores. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.92-47.39</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>11-16 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>45.473 +/- 41.617</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Blacks - Omnivores. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.919 +/- 19.503</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Blacks - Vegetarians. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>4.635</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Blacks - Vegetarians. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>33.624 +/- 36.360</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Whites - Omnivores. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>28.0954 +/- 31.826</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Whites - Omnivores. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.340 +/- 5.0764</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Whites - Vegetarians. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.334 +/- 2.759</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Whites - Vegetarians. From Exposome Explorer.</comment>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>30.0 +/- 43.0</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.036-184.27</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>4.6 +/- 2.7</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.3 +/- 5.1</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>46.1 +/- 53.5</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.9 +/- 19.5</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>28.1 +/- 31.8</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.3 +/- 2.76</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>45.5 +/- 41.6</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>33.6 +/- 36.4</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>18.55-145.2</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>21.329 +/- 12.971</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>53.18(22.81-139.9)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>47.06(17.31-146.8)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gonzalez-Dominguez R, Jauregui O, Queipo-Ortuno MI, Andres-Lacueva C: Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform. Anal Chem. 2020 Oct 20;92(20):13767-13775. doi: 10.1021/acs.analchem.0c02008. Epub 2020 Sep 30.</reference_text>
          <pubmed_id>32966057</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.13-166.96</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Under omnivorous diet</comment>
      <references>
        <reference>
          <reference_text>Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross AJ, Nicholson JK: Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006 Oct;5(10):2780-8.</reference_text>
          <pubmed_id>17022649</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>With fish (Salmon) consumption</comment>
      <references>
        <reference>
          <reference_text>Lloyd AJ, Beckmann M, Fave G, Mathers JC, Draper J: Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr. 2011 Sep;106(6):812-24. doi: 10.1017/S0007114511001164. Epub 2011 May  9.</reference_text>
          <pubmed_id>21736852</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Healthy condition not specified, assume it is healthy</comment>
      <references>
        <reference>
          <reference_text>Lloyd AJ, Beckmann M, Haldar S, Seal C, Brandt K, Draper J: Data-driven strategy for the discovery of potential urinary biomarkers of habitual dietary exposure. Am J Clin Nutr. 2013 Feb;97(2):377-89. doi: 10.3945/ajcn.112.048033. Epub 2012 Dec 26.</reference_text>
          <pubmed_id>23269817</pubmed_id>
        </reference>
      </references>
    </concentration>
  </normal_concentrations>
  <abnormal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>51.2 +/- 17.6 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
      <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>43.4 +/- 22.3 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>50.7 (12.9) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Early preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>50.0 (14.6) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>28.8 +/- 18.2</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Kidney disease</patient_information>
      <comment>Patients with chronic renal failure on maintenance hemodialysis. These subjects were treated with nocturnal hemodialysis for 8 h during the night, 6 times/week.</comment>
      <references>
        <reference>
          <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
          <pubmed_id>10838467</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>83.1 +/- 21.7</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Kidney disease</patient_information>
      <comment>Patients with chronic renal failure on maintenance hemodialysis. These subjects were treated with conventional hemodialysis for 4 h, 3 times/week.</comment>
      <references>
        <reference>
          <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
          <pubmed_id>10838467</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>70.3 (40.0) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Late-onset preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>38.9 (20.3) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>10.66 +/- 2.68</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Elderly (&gt;65 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <comment>Probable Alzheimer's disease</comment>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>40.4 (12.3) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Down syndrome pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>32.7 (13.7) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>2.6 +/- 1.13</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>10.9 +/- 10.1</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Obesity</patient_information>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>17.5 +/- 25.7</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>15.7 +/- 4.04</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Alzheimer's disease </patient_information>
      <comment>Probable Alzheimer's disease</comment>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>18.299 +/- 16.521</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>40 +/- 2.6</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Propionic acidemia </patient_information>
      <references>
        <reference>
          <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
          <pubmed_id>19551947</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>31 +/- 11</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Maple syrup urine disease </patient_information>
      <references>
        <reference>
          <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
          <pubmed_id>19551947</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>50.3 +/- 9.9</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Aminoaciduria</patient_information>
      <references>
        <reference>
          <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
          <pubmed_id>19551947</pubmed_id>
        </reference>
      </references>
    </concentration>
  </abnormal_concentrations>
  <diseases>
    <disease>
      <name>Kidney disease</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST: Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72.</reference_text>
          <pubmed_id>11380830</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
          <pubmed_id>11418788</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003 Jul;112(2):256-64.</reference_text>
          <pubmed_id>12865413</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P: Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol. 1991 Mar;44(3):243-5.</reference_text>
          <pubmed_id>2013627</pubmed_id>
        </reference>
        <reference>
          <reference_text>Niwa T, Takeda N, Yoshizumi H: RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. Kidney Int. 1998 Jun;53(6):1801-6.</reference_text>
          <pubmed_id>9607216</pubmed_id>
        </reference>
        <reference>
          <reference_text>Takagi T, Chung TG, Saito A: Determination of polyamines in hydrolysates of uremic plasma by high-performance cation-exchange column chromatography. J Chromatogr. 1983 Feb 11;272(2):279-85.</reference_text>
          <pubmed_id>6833425</pubmed_id>
        </reference>
        <reference>
          <reference_text>Burke RA, Moberly JB, Patel H, Shockley TR, Martis L: Maltose and isomaltose in uremic plasma following icodextrin administration. Adv Perit Dial. 1998;14:120-3.</reference_text>
          <pubmed_id>10649708</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fleck C, Schweitzer F, Karge E, Busch M, Stein G: Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta. 2003 Oct;336(1-2):1-12.</reference_text>
          <pubmed_id>14500028</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
          <pubmed_id>10838467</pubmed_id>
        </reference>
        <reference>
          <reference_text>Liebich HM, Woll J: Volatile substances in blood serum: profile analysis and quantitative determination. J Chromatogr. 1977 Nov 11;142:505-16.</reference_text>
          <pubmed_id>914932</pubmed_id>
        </reference>
        <reference>
          <reference_text>Galley HF, Le Cras AE, Yassen K, Grant IS, Webster NR: Circulating tetrahydrobiopterin concentrations in patients with septic shock. Br J Anaesth. 2001 Apr;86(4):578-80.</reference_text>
          <pubmed_id>11573638</pubmed_id>
        </reference>
        <reference>
          <reference_text>Paniagua R, Claure R, Amato D, Flores E, Perez A, Exaire E: Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients. Nephron. 1995;69(2):147-50.</reference_text>
          <pubmed_id>7723896</pubmed_id>
        </reference>
        <reference>
          <reference_text>Chuang CK, Lin SP, Chen HH, Chen YC, Wang TJ, Shieh WH, Wu CJ: Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Clin Chim Acta. 2006 Feb;364(1-2):209-16. Epub 2005 Aug 8.</reference_text>
          <pubmed_id>16087168</pubmed_id>
        </reference>
        <reference>
          <reference_text>Butscheid M, Schafer C, Brenner S, Alscher D, Murdter T, Niwa T, Frischmann M, Pischetsrieder M, Klotz U: Unchanged serum levels of advanced glycation endproducts in patients with liver disease. Naunyn Schmiedebergs Arch Pharmacol. 2007 Aug;375(6):401-6. Epub 2007 Jun 15.</reference_text>
          <pubmed_id>17571253</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stenvinkel P, Rodriguez-Ayala E, Massy ZA, Qureshi AR, Barany P, Fellstrom B, Heimburger O, Lindholm B, Alvestrand A: Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2006 Mar;1(2):281-7. Epub 2006 Feb 1.</reference_text>
          <pubmed_id>17699218</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bain MA, Faull R, Milne RW, Evans AM: Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab. 2006 Oct;7(7):811-6.</reference_text>
          <pubmed_id>17073580</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bain MA, Faull R, Fornasini G, Milne RW, Evans AM: Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant. 2006 May;21(5):1300-4. Epub 2006 Jan 9.</reference_text>
          <pubmed_id>16401621</pubmed_id>
        </reference>
        <reference>
          <reference_text>Teerlink T, Hennekes MW, Mulder C, Brulez HF: Determination of dimethylamine in biological samples by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):269-76.</reference_text>
          <pubmed_id>9174262</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H, Hosoya T: Plasma pteridine concentrations in patients with chronic renal failure. Nephrol Dial Transplant. 2002 Jun;17(6):1032-6.</reference_text>
          <pubmed_id>12032193</pubmed_id>
        </reference>
        <reference>
          <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
          <pubmed_id>17919531</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nieren- und Hochdruckkrankheiten (1978), 7(2), 62-74 (translated from German Kidney and Hypertension). </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Early preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pregnancy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
          <pubmed_id>3252730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
          <pubmed_id>663967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
          <pubmed_id>12833386</pubmed_id>
        </reference>
        <reference>
          <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
          <pubmed_id>2994907</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
          <pubmed_id>17704099</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
          <pubmed_id>12698507</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
          <pubmed_id>17061063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
          <pubmed_id>16925883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
          <pubmed_id>22420377</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
          <pubmed_id>18059417</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
        <reference>
          <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Late-onset preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Alzheimer's disease</name>
      <omim_id>104300</omim_id>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
        <reference>
          <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
          <pubmed_id>11959400</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
          <pubmed_id>8595727</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
          <pubmed_id>15361288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
          <pubmed_id>15465626</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
          <pubmed_id>15061359</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
          <pubmed_id>10494443</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
          <pubmed_id>11255442</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
          <pubmed_id>12498967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
          <pubmed_id>16227558</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
          <pubmed_id>9720975</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
          <pubmed_id>12111441</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
          <pubmed_id>16244393</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
          <pubmed_id>8356878</pubmed_id>
        </reference>
        <reference>
          <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
          <pubmed_id>12391605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
          <pubmed_id>8478958</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
          <pubmed_id>21292280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
          <pubmed_id>20858978</pubmed_id>
        </reference>
        <reference>
          <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
          <pubmed_id>21474939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
          <pubmed_id>20523031</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
          <pubmed_id>11314776</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
          <pubmed_id>1716470</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Obesity</name>
      <omim_id>601665</omim_id>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
          <pubmed_id>16253646</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N: Obese men have elevated plasma levels of estrone sulfate. Int J Obes. 1990 Jun;14(6):483-6.</reference_text>
          <pubmed_id>2401584</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP: Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.</reference_text>
          <pubmed_id>17264178</pubmed_id>
        </reference>
        <reference>
          <reference_text>Driskell JA, Chrisley BM, Reynolds LK, Moak SW: Plasma B6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of middle-aged obese black women. J Chromatogr. 1991 Aug 23;568(2):333-40.</reference_text>
          <pubmed_id>1783639</pubmed_id>
        </reference>
        <reference>
          <reference_text>Haro C, Montes-Borrego M, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, Lopez-Miranda J, Camargo A, Perez-Jimenez F: Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J Clin Endocrinol Metab. 2016 Jan;101(1):233-42. doi: 10.1210/jc.2015-3351. Epub  2015 Oct 27.</reference_text>
          <pubmed_id>26505825</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86.</reference_text>
          <pubmed_id>17408529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6.</reference_text>
          <pubmed_id>18997681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr  17.</reference_text>
          <pubmed_id>24740590</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4.</reference_text>
          <pubmed_id>23108202</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22.</reference_text>
          <pubmed_id>26910390</pubmed_id>
        </reference>
        <reference>
          <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Diabetes mellitus type 2</name>
      <omim_id>125853</omim_id>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.</reference_text>
          <pubmed_id>11887176</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.</reference_text>
          <pubmed_id>16731998</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
          <pubmed_id>15982426</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.</reference_text>
          <pubmed_id>10431355</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
          <pubmed_id>6810706</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.</reference_text>
          <pubmed_id>7758205</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.</reference_text>
          <pubmed_id>9357814</pubmed_id>
        </reference>
        <reference>
          <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
          <pubmed_id>14512036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
          <pubmed_id>12067838</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.</reference_text>
          <pubmed_id>17161231</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.</reference_text>
          <pubmed_id>11315839</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.</reference_text>
          <pubmed_id>17659063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.</reference_text>
          <pubmed_id>17705693</pubmed_id>
        </reference>
        <reference>
          <reference_text>McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.</reference_text>
          <pubmed_id>1456422</pubmed_id>
        </reference>
        <reference>
          <reference_text>Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.</reference_text>
          <pubmed_id>484160</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.</reference_text>
          <pubmed_id>8234346</pubmed_id>
        </reference>
        <reference>
          <reference_text>Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.</reference_text>
          <pubmed_id>9591306</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.</reference_text>
          <pubmed_id>16966827</pubmed_id>
        </reference>
        <reference>
          <reference_text>Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.</reference_text>
          <pubmed_id>7096503</pubmed_id>
        </reference>
        <reference>
          <reference_text>Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.</reference_text>
          <pubmed_id>2614280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.</reference_text>
          <pubmed_id>18760976</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.</reference_text>
          <pubmed_id>11815509</pubmed_id>
        </reference>
        <reference>
          <reference_text>Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.</reference_text>
          <pubmed_id>10694785</pubmed_id>
        </reference>
        <reference>
          <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
          <pubmed_id>17919531</pubmed_id>
        </reference>
        <reference>
          <reference_text>Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.</reference_text>
          <pubmed_id>17190852</pubmed_id>
        </reference>
        <reference>
          <reference_text>Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.</reference_text>
          <pubmed_id>22031514</pubmed_id>
        </reference>
        <reference>
          <reference_text>Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013  May 2.</reference_text>
          <pubmed_id>23637065</pubmed_id>
        </reference>
        <reference>
          <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Rosa Va ́zquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study.  Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Propionic acidemia</name>
      <omim_id>606054</omim_id>
      <references>
        <reference>
          <reference_text>Scholl-Burgi S, Haberlandt E, Gotwald T, Albrecht U, Baumgartner Sigl S, Rauchenzauner M, Rostasy K, Karall D: Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation. Neuropediatrics. 2009 Apr;40(2):76-81. doi: 10.1055/s-0029-1231065. Epub 2009 Oct 6.</reference_text>
          <pubmed_id>19809936</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
          <pubmed_id>19551947</pubmed_id>
        </reference>
        <reference>
          <reference_text>Thompson GN, Chalmers RA, Walter JH, Bresson JL, Lyonnet SL, Reed PJ, Saudubray JM, Leonard JV, Halliday D: The use of metronidazole in management of methylmalonic and propionic acidaemias. Eur J Pediatr. 1990 Aug;149(11):792-6.</reference_text>
          <pubmed_id>2226555</pubmed_id>
        </reference>
        <reference>
          <reference_text>Riemersma M, Hazebroek MR, Helderman-van den Enden ATJM, Salomons GS, Ferdinandusse S, Brouwers MCGJ, van der Ploeg L, Heymans S, Glatz JFC, van den Wijngaard A, Krapels IPC, Bierau J, Brunner HG: Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017 Nov;25(11):1195-1201. doi: 10.1038/ejhg.2017.127. Epub 2017 Aug 30.</reference_text>
          <pubmed_id>28853722</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Maple syrup urine disease</name>
      <omim_id>248600</omim_id>
      <references>
        <reference>
          <reference_text>Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.</reference_text>
          <pubmed_id>12101068</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U: Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem. 1999 Oct;45(10):1734-40.</reference_text>
          <pubmed_id>10508118</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schadewaldt P, Hammen HW, Ott AC, Wendel U: Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis. 1999 Aug;22(6):706-22.</reference_text>
          <pubmed_id>10472531</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
          <pubmed_id>19551947</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
          <pubmed_id>11978597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Podebrad F, Heil M, Reichert S, Mosandl A, Sewell AC, Bohles H: 4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease. J Inherit Metab Dis. 1999 Apr;22(2):107-14.</reference_text>
          <pubmed_id>10234605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9.</reference_text>
          <pubmed_id>6422161</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yunus ZM, Kamaludin DA, Mamat M, Choy YS, Ngu L: Clinical and biochemical profiles of maple syrup urine disease in malaysian children. JIMD Rep. 2012;5:99-107. doi: 10.1007/8904_2011_105. Epub 2011 Dec 11.</reference_text>
          <pubmed_id>23430924</pubmed_id>
        </reference>
        <reference>
          <reference_text>Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR: Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem. 2008 Mar;41(4-5):317-24. Epub 2007 Dec 5.</reference_text>
          <pubmed_id>18088602</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 134: 57. https://doi.org/10.1007/BF00442404</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Eosinophilic esophagitis</name>
      <omim_id>610247</omim_id>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
  </diseases>
  <chemspider_id>83153</chemspider_id>
  <drugbank_id>DB04151</drugbank_id>
  <foodb_id>FDB093588</foodb_id>
  <pubchem_compound_id>92105</pubchem_compound_id>
  <pdb_id/>
  <chebi_id>50599</chebi_id>
  <phenol_explorer_compound_id/>
  <knapsack_id>C00052105</knapsack_id>
  <kegg_id>C01152</kegg_id>
  <biocyc_id/>
  <bigg_id/>
  <wikipedia_id>Methylhistidine</wikipedia_id>
  <metlin_id>3741</metlin_id>
  <vmh_id/>
  <fbonto_id/>
  <synthesis_reference>Jain, Rahul; Cohen, Louis A. Regiospecific alkylation of histidine and histamine at N-1 (t).Tetrahedron  (1996),  52(15),  5363-70.</synthesis_reference>
  <general_references>
    <reference>
      <reference_text>Colombani PC, Kovacs E, Frey-Rindova P, Frey W, Langhans W, Arnold M, Wenk C: Metabolic effects of a protein-supplemented carbohydrate drink in marathon runners. Int J Sport Nutr. 1999 Jun;9(2):181-201.</reference_text>
      <pubmed_id>10362454</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 Mar 1;67(5):793-811.</reference_text>
      <pubmed_id>7762816</pubmed_id>
    </reference>
    <reference>
      <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
      <pubmed_id>11052553</pubmed_id>
    </reference>
    <reference>
      <reference_text>Giesecke K, Magnusson I, Ahlberg M, Hagenfeldt L, Wahren J: Protein and amino acid metabolism during early starvation as reflected by excretion of urea and methylhistidines. Metabolism. 1989 Dec;38(12):1196-200.</reference_text>
      <pubmed_id>2593832</pubmed_id>
    </reference>
    <reference>
      <reference_text>Vranic L, Granic P, Rajic Z: Basic amino acid in the pathogenesis of caries. Acta Stomatol Croat. 1991;25(2):71-6.</reference_text>
      <pubmed_id>1819935</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sjolin J, Stjernstrom H, Henneberg S, Hambraeus L, Friman G: Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios. Am J Clin Nutr. 1989 Jan;49(1):62-70.</reference_text>
      <pubmed_id>2912013</pubmed_id>
    </reference>
    <reference>
      <reference_text>COCKS DH, DENNIS PO, NELSON TH: ISOLATION OF 3-METHYL HISTIDINE FROM WHALEMEAT EXTRACT AND THE PREPARATION OF SOME DERIVATIVES. Nature. 1964 Apr 11;202:184-5.</reference_text>
      <pubmed_id>14156296</pubmed_id>
    </reference>
    <reference>
      <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
      <pubmed_id>7061274</pubmed_id>
    </reference>
    <reference>
      <reference_text>Garlick PJ, McNurlan MA, Bark T, Lang CH, Gelato MC: Hormonal regulation of protein metabolism in relation to nutrition and disease. J Nutr. 1998 Feb;128(2 Suppl):356S-359S.</reference_text>
      <pubmed_id>9478024</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
      <pubmed_id>15899597</pubmed_id>
    </reference>
    <reference>
      <reference_text>Dunnett M, Harris RC: High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatogr B Biomed Sci Appl. 1997 Jan 10;688(1):47-55.</reference_text>
      <pubmed_id>9029312</pubmed_id>
    </reference>
    <reference>
      <reference_text>Betto P, Ricciarello G, Pichini S, Dello Strologo L, Rizzoni G: High-performance liquid chromatography-electrochemical detection of 3-methylhistidine in human urine. J Chromatogr. 1992 Dec 23;584(2):256-60.</reference_text>
      <pubmed_id>1484110</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
      <pubmed_id>32033212</pubmed_id>
    </reference>
    <reference>
      <reference_text>Boldyrev AA, Aldini G, Derave W: Physiology and pathophysiology of carnosine. Physiol Rev. 2013 Oct;93(4):1803-45. doi: 10.1152/physrev.00039.2012.</reference_text>
      <pubmed_id>24137022</pubmed_id>
    </reference>
    <reference>
      <reference_text>Davydova E, Shimazu T, Schuhmacher MK, Jakobsson ME, Willemen HLDM, Liu T, Moen A, Ho AYY, Malecki J, Schroer L, Pinto R, Suzuki T, Gronsberg IA, Sohtome Y, Akakabe M, Weirich S, Kikuchi M, Olsen JV, Dohmae N, Umehara T, Sodeoka M, Siino V, McDonough MA, Eijkelkamp N, Schofield CJ, Jeltsch A, Shinkai Y, Falnes PO: The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes. Nat Commun. 2021 Feb 9;12(1):891. doi: 10.1038/s41467-020-20670-7.</reference_text>
      <pubmed_id>33563959</pubmed_id>
    </reference>
    <reference>
      <reference_text>Cross AJ, Major JM, Sinha R: Urinary biomarkers of meat consumption. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1107-11. doi: 10.1158/1055-9965.EPI-11-0048. Epub 2011 Apr 28.</reference_text>
      <pubmed_id>21527577</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mitry P, Wawro N, Rohrmann S, Giesbertz P, Daniel H, Linseisen J: Plasma concentrations of anserine, carnosine and pi-methylhistidine as biomarkers of habitual meat consumption. Eur J Clin Nutr. 2019 May;73(5):692-702. doi: 10.1038/s41430-018-0248-1. Epub 2018 Jul 17.</reference_text>
      <pubmed_id>30018457</pubmed_id>
    </reference>
  </general_references>
  <protein_associations>
    <protein>
      <protein_accession>HMDBP00473</protein_accession>
      <name>Beta-Ala-His dipeptidase</name>
      <uniprot_id>Q96KN2</uniprot_id>
      <gene_name>CNDP1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00474</protein_accession>
      <name>Protein arginine N-methyltransferase 3</name>
      <uniprot_id>O60678</uniprot_id>
      <gene_name>PRMT3</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
  </protein_associations>
</metabolite>
<metabolite>
  <version>5.0</version>
  <creation_date>2005-11-16 15:48:42 UTC</creation_date>
  <update_date>2020-11-09 23:11:34 UTC</update_date>
  <accession>HMDB0000005</accession>
  <status>quantified</status>
  <secondary_accessions>
    <accession>HMDB00005</accession>
    <accession>HMDB0006544</accession>
    <accession>HMDB06544</accession>
  </secondary_accessions>
  <name>2-Ketobutyric acid</name>
  <description>2-Ketobutyric acid, also known as alpha-ketobutyrate or 2-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted into succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle. More specifically, 2-ketobutyric acid is a product of the lysis of cystathionine.</description>
  <synonyms>
    <synonym>2-Ketobutanoic acid</synonym>
    <synonym>2-Oxobutyric acid</synonym>
    <synonym>3-Methyl pyruvic acid</synonym>
    <synonym>alpha-Ketobutyrate</synonym>
    <synonym>alpha-Ketobutyric acid</synonym>
    <synonym>alpha-oxo-N-Butyric acid</synonym>
    <synonym>2-Oxobutyrate</synonym>
    <synonym>2-Oxobutanoic acid</synonym>
    <synonym>2-Ketobutanoate</synonym>
    <synonym>3-Methyl pyruvate</synonym>
    <synonym>a-Ketobutyrate</synonym>
    <synonym>a-Ketobutyric acid</synonym>
    <synonym>Α-ketobutyrate</synonym>
    <synonym>Α-ketobutyric acid</synonym>
    <synonym>a-oxo-N-Butyrate</synonym>
    <synonym>a-oxo-N-Butyric acid</synonym>
    <synonym>alpha-oxo-N-Butyrate</synonym>
    <synonym>Α-oxo-N-butyrate</synonym>
    <synonym>Α-oxo-N-butyric acid</synonym>
    <synonym>2-Oxobutanoate</synonym>
    <synonym>2-Ketobutyrate</synonym>
    <synonym>2-oxo-Butanoate</synonym>
    <synonym>2-oxo-Butanoic acid</synonym>
    <synonym>2-oxo-Butyrate</synonym>
    <synonym>2-oxo-Butyric acid</synonym>
    <synonym>2-oxo-N-Butyrate</synonym>
    <synonym>2-oxo-N-Butyric acid</synonym>
    <synonym>3-Methylpyruvate</synonym>
    <synonym>3-Methylpyruvic acid</synonym>
    <synonym>a-Keto-N-butyrate</synonym>
    <synonym>a-Keto-N-butyric acid</synonym>
    <synonym>a-Oxobutyrate</synonym>
    <synonym>a-Oxobutyric acid</synonym>
    <synonym>alpha-Keto-N-butyrate</synonym>
    <synonym>alpha-Keto-N-butyric acid</synonym>
    <synonym>alpha-Ketobutric acid</synonym>
    <synonym>alpha-Oxobutyrate</synonym>
    <synonym>alpha-Oxobutyric acid</synonym>
    <synonym>Methyl-pyruvate</synonym>
    <synonym>Methyl-pyruvic acid</synonym>
    <synonym>Propionyl-formate</synonym>
    <synonym>Propionyl-formic acid</synonym>
    <synonym>alpha-Ketobutyric acid, sodium salt</synonym>
    <synonym>2-Ketobutyric acid</synonym>
  </synonyms>
  <chemical_formula>C4H6O3</chemical_formula>
  <average_molecular_weight>102.0886</average_molecular_weight>
  <monisotopic_molecular_weight>102.031694058</monisotopic_molecular_weight>
  <iupac_name>2-oxobutanoic acid</iupac_name>
  <traditional_iupac>2-oxobutanoic acid</traditional_iupac>
  <cas_registry_number>600-18-0</cas_registry_number>
  <smiles>CCC(=O)C(O)=O</smiles>
  <inchi>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</inchi>
  <inchikey>TYEYBOSBBBHJIV-UHFFFAOYSA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms.</description>
    <direct_parent>Short-chain keto acids and derivatives</direct_parent>
    <kingdom>Organic compounds</kingdom>
    <super_class>Organic acids and derivatives</super_class>
    <class>Keto acids and derivatives</class>
    <sub_class>Short-chain keto acids and derivatives</sub_class>
    <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
    <alternative_parents>
      <alternative_parent>Alpha-hydroxy ketones</alternative_parent>
      <alternative_parent>Alpha-keto acids and derivatives</alternative_parent>
      <alternative_parent>Carboxylic acids</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
      <alternative_parent>Organic oxides</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>Aliphatic acyclic compound</substituent>
      <substituent>Alpha-hydroxy ketone</substituent>
      <substituent>Alpha-keto acid</substituent>
      <substituent>Carbonyl group</substituent>
      <substituent>Carboxylic acid</substituent>
      <substituent>Carboxylic acid derivative</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>Ketone</substituent>
      <substituent>Monocarboxylic acid or derivatives</substituent>
      <substituent>Organic oxide</substituent>
      <substituent>Organic oxygen compound</substituent>
      <substituent>Organooxygen compound</substituent>
      <substituent>Short-chain keto acid</substituent>
    </substituents>
    <external_descriptors>
      <external_descriptor>2-oxo monocarboxylic acid</external_descriptor>
      <external_descriptor>Oxo fatty acids</external_descriptor>
      <external_descriptor>Oxo fatty acids</external_descriptor>
      <external_descriptor>short-chain fatty acid</external_descriptor>
    </external_descriptors>
  </taxonomy>
  <ontology>
    <root>
      <term>Disposition</term>
      <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Route of exposure</term>
          <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Enteral</term>
              <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
              <parent_id>7743</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Ingestion</term>
                  <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                  <parent_id>7744</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Digestion</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Source</term>
          <definition>Natural or synthetic origin of a chemical.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Endogenous</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Food</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Biological</term>
              <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Plant</term>
                  <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                    <synonym>Flora</synonym>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Poaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Gramineae</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Fabaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Papilionoideae</synonym>
                        <synonym>Legume</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Glycine max</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Soy</synonym>
                        <synonym>Soya</synonym>
                        <synonym>Soybean</synonym>
                        <synonym>Soya bean</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cucurbitaceae</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cucurbits</synonym>
                        <synonym>Gourds</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Theobroma cacao</term>
                      <definition/>
                      <parent_id>7738</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Animal</term>
                  <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fauna</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological location</term>
          <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biofluid and excreta</term>
              <definition>A liquid, semi-solid or solid material originating in the body.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Saliva</term>
                  <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Urine</term>
                  <definition>Excretion in liquid state processed by the kidney.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Blood</term>
                  <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cerebrospinal fluid</term>
                  <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Csf</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Subcellular</term>
              <definition>An anatomical organizational level including a component within a biological cell .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cytoplasm</term>
                  <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Cytoplasma</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Process</term>
      <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Naturally occurring process</term>
          <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
          <parent_id>7659</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biological process</term>
              <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
              <parent_id>7660</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biochemical pathway</term>
                  <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                  <parent_id>7661</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Glycine and Serine Metabolism</term>
                      <definition> all of these compounds share common intermediates and almost all can be biosynthesized from one another. serine and glycine are not essential amino acids and can be synthesized from a number of routes.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Homocysteine Degradation</term>
                      <definition> in mammals, homocysteine is used to biosynthesize cysteine via the following pathway. first the enzyme cystathionine beta-synthetase irreversibly condenses homocysteine with l-serine, forming l-cystathionine.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Methionine Metabolism</term>
                      <definition> these pathways share 3 common reactions with both including the conversion of methionine to s-adenosylmethionine (sam),the utilization of sam in diverse transmethylation reactions yielding a methylated product plus s-adenosylhomocysteine, and the cleavage of s-adenosylhomocysteine to yield homocysteine and adenosine. the transulfuration reactions that produce cysteine from homocysteine and serine also produce α-ketobutyrate, the latter being converted first to propionyl-coa and then via a 3-step process to succinyl-coa.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Propanoate Metabolism</term>
                      <definition> alternatively, propionyl-coa results from the oxidative decarboxylation of 2-ketobutyric acid. this reaction is mediated by a large, multienzyme complex such as the branched-chain alpha-keto acid dehydrogenase complex.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Selenoamino Acid Metabolism</term>
                      <definition> these include selenocysteine, selenohomocysteine and selenomethionine. selenium and sulfur are chalcogen elements that share many chemical properties and so the substitution of normal (sulfur-containing) amino acids with selenoamino acids has little effect on protein structure and function.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Threonine and 2-Oxobutanoate Degradation</term>
                      <definition> in humans, threonine is converted to 2-oxobutanoate via serine dehydratase, and thereby enters the pathway leading to succinyl-coa. this is the major route for threonine degradation in humans.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Role</term>
      <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Industrial application</term>
          <definition>The assumed function of a chemical utilized by human.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Pharmaceutical industry</term>
              <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
              <parent_id>7678</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical</term>
                  <definition/>
                  <parent_id>7679</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
  </ontology>
  <state>Solid</state>
  <experimental_properties>
    <property>
      <kind>water_solubility</kind>
      <value>119 mg/mL</value>
      <source/>
    </property>
    <property>
      <kind>melting_point</kind>
      <value>33 °C</value>
      <source/>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>0.07</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>-0.11</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>79.2 g/L</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>0.77</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>3.19</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>-9.7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>2-oxobutanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>102.0886</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>102.031694058</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>CCC(=O)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C4H6O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>TYEYBOSBBBHJIV-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>54.37</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>22.62</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>9.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <spectra>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>917</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>276</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>277</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>936</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>937</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>943</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>3474</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30041</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30042</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30433</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30434</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30943</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30944</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30945</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31982</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>31983</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>37238</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>170694</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1024</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>4754</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>4755</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>7</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>8</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>9</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2522</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>20636</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>20637</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>20638</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>22187</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>22188</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>22189</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>439247</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1473310</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1473311</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1473312</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1473313</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1473314</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2660341</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2660342</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2660343</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3018696</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3018697</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>3018698</spectrum_id>
    </spectrum>
  </spectra>
  <biological_properties>
    <cellular_locations>
      <cellular>Cytoplasm</cellular>
    </cellular_locations>
    <biospecimen_locations>
      <biospecimen>Blood</biospecimen>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <biospecimen>Saliva</biospecimen>
      <biospecimen>Urine</biospecimen>
    </biospecimen_locations>
    <tissue_locations>
    </tissue_locations>
    <pathways>
      <pathway>
        <name>3-Phosphoglycerate dehydrogenase deficiency</name>
        <smpdb_id>SMP00721</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Cystathionine Beta-Synthase Deficiency</name>
        <smpdb_id>SMP00177</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Dihydropyrimidine Dehydrogenase Deficiency (DHPD)</name>
        <smpdb_id>SMP00179</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Dimethylglycine Dehydrogenase Deficiency</name>
        <smpdb_id>SMP00242</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Dimethylglycine Dehydrogenase Deficiency</name>
        <smpdb_id>SMP00484</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Gamma-cystathionase deficiency (CTH)</name>
        <smpdb_id>SMP00514</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycine N-methyltransferase Deficiency</name>
        <smpdb_id>SMP00222</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Glycine, serine and threonine metabolism</name>
        <smpdb_id/>
        <kegg_map_id>map00260</kegg_map_id>
      </pathway>
      <pathway>
        <name>Homocysteine Degradation</name>
        <smpdb_id>SMP00455</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>Homocystinuria, cystathionine beta-synthase deficiency</name>
        <smpdb_id>SMP00515</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type</name>
        <smpdb_id>SMP00570</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Hyperglycinemia, non-ketotic</name>
        <smpdb_id>SMP00485</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Hypermethioninemia</name>
        <smpdb_id>SMP00341</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Malonic Aciduria</name>
        <smpdb_id>SMP00198</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Malonyl-coa decarboxylase deficiency</name>
        <smpdb_id>SMP00502</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Methionine Adenosyltransferase Deficiency</name>
        <smpdb_id>SMP00221</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Methionine Metabolism</name>
        <smpdb_id>SMP00033</smpdb_id>
        <kegg_map_id>map00270</kegg_map_id>
      </pathway>
      <pathway>
        <name>Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)</name>
        <smpdb_id>SMP00340</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Methylmalonic Aciduria Due to Cobalamin-Related Disorders</name>
        <smpdb_id>SMP00201</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Non Ketotic Hyperglycinemia</name>
        <smpdb_id>SMP00223</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Propanoate metabolism</name>
        <smpdb_id/>
        <kegg_map_id>map00640</kegg_map_id>
      </pathway>
      <pathway>
        <name>S-Adenosylhomocysteine (SAH) Hydrolase Deficiency</name>
        <smpdb_id>SMP00214</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Sarcosinemia</name>
        <smpdb_id>SMP00244</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Selenocompound metabolism</name>
        <smpdb_id/>
        <kegg_map_id>map00450</kegg_map_id>
      </pathway>
      <pathway>
        <name>Threonine and 2-Oxobutanoate Degradation</name>
        <smpdb_id>SMP00452</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
    </pathways>
  </biological_properties>
  <normal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>3.33 +/- 5.00</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Yang W, Roth KS: Defect in alpha-ketobutyrate metabolism: a new inborn error. Clin Chim Acta. 1985 Jan 30;145(2):173-82.</reference_text>
          <pubmed_id>3918815</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>9.4 (3.4-15.4)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
          <pubmed_id>9869358</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>8.6 (6.0-11.2)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Rocchiccioli F, Leroux JP, Cartier PH: Microdetermination of 2-ketoglutaric acid in plasma and cerebrospinal fluid by capillary gas chromatography mass spectrometry; application to pediatrics. Biomed Mass Spectrom. 1984 Jan;11(1):24-8.</reference_text>
          <pubmed_id>6704500</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gonzalez-Dominguez R, Jauregui O, Queipo-Ortuno MI, Andres-Lacueva C: Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform. Anal Chem. 2020 Oct 20;92(20):13767-13775. doi: 10.1021/acs.analchem.0c02008. Epub 2020 Sep 30.</reference_text>
          <pubmed_id>32966057</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>4.8 (3.4-6.2)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Rocchiccioli F, Leroux JP, Cartier PH: Microdetermination of 2-ketoglutaric acid in plasma and cerebrospinal fluid by capillary gas chromatography mass spectrometry; application to pediatrics. Biomed Mass Spectrom. 1984 Jan;11(1):24-8.</reference_text>
          <pubmed_id>6704500</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>0.0412 +/- 0.214</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected at 16:00 (n=27)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>2.62 +/- 4.13</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>BMI ≥ 21.00 kg/m2 (n=22)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>4.06 +/- 8.39</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected at 16:00 (n=24)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>4.12 +/- 4.41</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>BMI &lt; 21.00 kg/m2 (n=45)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.39 (0.05-2.2)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
          <pubmed_id>9869358</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.13 (0.04-0.51)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
          <pubmed_id>9869358</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Urine compound detected by GC-MS</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>9.476 +/- 6.626</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.9 (0.7-5.4)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>urine by NMR</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.6 (1.1-4.1) </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Shaykhutdinov RA, MacInnis GD, Dowlatabadi R, Weljie AM, Vogel HJ.  Quantitative analysis of metabolite concentrations in human urine samples using 13C{1H} NMR spectroscopy.  Metabolomics.  2009</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gonzalez-Dominguez R, Jauregui O, Queipo-Ortuno MI, Andres-Lacueva C: Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform. Anal Chem. 2020 Oct 20;92(20):13767-13775. doi: 10.1021/acs.analchem.0c02008. Epub 2020 Sep 30.</reference_text>
          <pubmed_id>32966057</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0-50</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By H-NMR 600 MHz BRUKER spectrometers</comment>
      <references>
        <reference>
          <reference_text>Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Anso S, Echevarria LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MA, Legorburu AP, Fang F, Astigarraga I, Schafer H, Spraul M, Millet O: NMR-based newborn urine screening for optimized detection of inherited errors of metabolism. Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.</reference_text>
          <pubmed_id>31506554</pubmed_id>
        </reference>
      </references>
    </concentration>
  </normal_concentrations>
  <abnormal_concentrations>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6.564 +/- 7.802</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
  </abnormal_concentrations>
  <diseases>
    <disease>
      <name>Eosinophilic esophagitis</name>
      <omim_id>610247</omim_id>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
  </diseases>
  <kegg_id>C00109</kegg_id>
  <drugbank_id>DB04553</drugbank_id>
  <foodb_id>FDB030356</foodb_id>
  <chemspider_id>57</chemspider_id>
  <pubchem_compound_id>58</pubchem_compound_id>
  <pdb_id/>
  <chebi_id>30831</chebi_id>
  <knapsack_id>C00019675</knapsack_id>
  <biocyc_id>2-OXOBUTANOATE</biocyc_id>
  <wikipedia_id>Alpha-Ketobutyric_acid</wikipedia_id>
  <phenol_explorer_compound_id/>
  <bigg_id>33889</bigg_id>
  <metlin_id/>
  <vmh_id>2OBUT</vmh_id>
  <fbonto_id/>
  <synthesis_reference>Figge, Rainer; Lux, Fabien; Raynaud, Celine; Soucaille, Philippe. Production of a-ketobutyrate by engineered Escherichia coli.PCT Int. Appl.  (2006), 31pp.  </synthesis_reference>
  <general_references>
    <reference>
      <reference_text>Sprague CL, Elfarra AA: Detection of carboxylic acids and inhibition of hippuric acid formation in rats treated with 3-butene-1,2-diol, a major metabolite of 1,3-butadiene. Drug Metab Dispos. 2003 Aug;31(8):986-92.</reference_text>
      <pubmed_id>12867486</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yaegaki K, Sanada K: Biochemical and clinical factors influencing oral malodor in periodontal patients. J Periodontol. 1992 Sep;63(9):783-9.</reference_text>
      <pubmed_id>1474480</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yaegaki K, Sanada K: Effects of a two-phase oil-water mouthwash on halitosis. Clin Prev Dent. 1992 Jan-Feb;14(1):5-9.</reference_text>
      <pubmed_id>1499240</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yang W, Roth KS: Defect in alpha-ketobutyrate metabolism: a new inborn error. Clin Chim Acta. 1985 Jan 30;145(2):173-82.</reference_text>
      <pubmed_id>3918815</pubmed_id>
    </reference>
  </general_references>
  <protein_associations>
    <protein>
      <protein_accession>HMDBP00012</protein_accession>
      <name>Pyruvate dehydrogenase E1 component subunit beta, mitochondrial</name>
      <uniprot_id>P11177</uniprot_id>
      <gene_name>PDHB</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00046</protein_accession>
      <name>Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial</name>
      <uniprot_id>P08559</uniprot_id>
      <gene_name>PDHA1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00050</protein_accession>
      <name>Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial</name>
      <uniprot_id>P29803</uniprot_id>
      <gene_name>PDHA2</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00299</protein_accession>
      <name>2-oxoisovalerate dehydrogenase subunit beta, mitochondrial</name>
      <uniprot_id>P21953</uniprot_id>
      <gene_name>BCKDHB</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00300</protein_accession>
      <name>2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial</name>
      <uniprot_id>P12694</uniprot_id>
      <gene_name>BCKDHA</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00439</protein_accession>
      <name>2-oxoglutarate dehydrogenase, mitochondrial</name>
      <uniprot_id>Q02218</uniprot_id>
      <gene_name>OGDH</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00538</protein_accession>
      <name>Cystathionine gamma-lyase</name>
      <uniprot_id>P32929</uniprot_id>
      <gene_name>CTH</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00671</protein_accession>
      <name>L-serine dehydratase/L-threonine deaminase</name>
      <uniprot_id>P20132</uniprot_id>
      <gene_name>SDS</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00893</protein_accession>
      <name>L-lactate dehydrogenase A-like 6A</name>
      <uniprot_id>Q6ZMR3</uniprot_id>
      <gene_name>LDHAL6A</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00914</protein_accession>
      <name>Urocanate hydratase</name>
      <uniprot_id>Q96N76</uniprot_id>
      <gene_name>UROC1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP01493</protein_accession>
      <name>[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial</name>
      <uniprot_id>O14874</uniprot_id>
      <gene_name>BCKDK</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03577</protein_accession>
      <name>L-lactate dehydrogenase B chain</name>
      <uniprot_id>P07195</uniprot_id>
      <gene_name>LDHB</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03578</protein_accession>
      <name>L-lactate dehydrogenase C chain</name>
      <uniprot_id>P07864</uniprot_id>
      <gene_name>LDHC</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03579</protein_accession>
      <name>L-lactate dehydrogenase A chain</name>
      <uniprot_id>P00338</uniprot_id>
      <gene_name>LDHA</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03581</protein_accession>
      <name>L-lactate dehydrogenase A-like 6B</name>
      <uniprot_id>Q9BYZ2</uniprot_id>
      <gene_name>LDHAL6B</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03654</protein_accession>
      <name>Trimethyllysine dioxygenase, mitochondrial</name>
      <uniprot_id>Q9NVH6</uniprot_id>
      <gene_name>TMLHE</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP08668</protein_accession>
      <name>Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2</name>
      <uniprot_id>Q6NS38</uniprot_id>
      <gene_name>ALKBH2</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP08669</protein_accession>
      <name>Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3</name>
      <uniprot_id>Q96Q83</uniprot_id>
      <gene_name>ALKBH3</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP08972</protein_accession>
      <name>Serine dehydratase-like</name>
      <uniprot_id>Q96GA7</uniprot_id>
      <gene_name>SDSL</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP09100</protein_accession>
      <name>2-oxoglutarate dehydrogenase-like, mitochondrial</name>
      <uniprot_id>Q9ULD0</uniprot_id>
      <gene_name>OGDHL</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP09101</protein_accession>
      <name>2-oxoglutarate receptor 1</name>
      <uniprot_id>Q96P68</uniprot_id>
      <gene_name>OXGR1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
  </protein_associations>
</metabolite>
<metabolite>
  <version>5.0</version>
  <creation_date>2005-11-16 15:48:42 UTC</creation_date>
  <update_date>2021-09-14 15:44:51 UTC</update_date>
  <accession>HMDB0000008</accession>
  <status>quantified</status>
  <secondary_accessions>
    <accession>HMDB00008</accession>
  </secondary_accessions>
  <name>2-Hydroxybutyric acid</name>
  <description>2-Hydroxybutyric acid (CAS: 600-15-7), also known as alpha-hydroxybutyrate, is an organic acid derived from alpha-ketobutyrate. alpha-Ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized into propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a byproduct from the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH). alpha-Hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). alpha-Ketobutyrate is released as a byproduct when cystathionine is cleaved into cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-Hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g. birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as "cerebral" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early-stage type II diabetes (PMID: 19166731). It was concluded from studies done in the mid-1970s that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydroxybutyric acid (PMID: 168632).</description>
  <synonyms>
    <synonym>(S)-2-Hydroxybutanoic acid</synonym>
    <synonym>2-Hydroxybutyrate</synonym>
    <synonym>2-Hydroxybutyric acid</synonym>
    <synonym>L-2-Hydroxybutanoic acid</synonym>
    <synonym>L-2-Hydroxybutyric acid</synonym>
    <synonym>L-alpha-Hydroxybutanoic acid</synonym>
    <synonym>L-alpha-Hydroxybutyric acid</synonym>
    <synonym>(S)-2-Hydroxybutanoate</synonym>
    <synonym>L-2-Hydroxybutanoate</synonym>
    <synonym>L-2-Hydroxybutyrate</synonym>
    <synonym>L-a-Hydroxybutanoate</synonym>
    <synonym>L-a-Hydroxybutanoic acid</synonym>
    <synonym>L-alpha-Hydroxybutanoate</synonym>
    <synonym>L-Α-hydroxybutanoate</synonym>
    <synonym>L-Α-hydroxybutanoic acid</synonym>
    <synonym>L-a-Hydroxybutyrate</synonym>
    <synonym>L-a-Hydroxybutyric acid</synonym>
    <synonym>L-alpha-Hydroxybutyrate</synonym>
    <synonym>L-Α-hydroxybutyrate</synonym>
    <synonym>L-Α-hydroxybutyric acid</synonym>
    <synonym>(S)-2-Hydroxybutyrate</synonym>
    <synonym>2-Hydroxybutanoate</synonym>
    <synonym>(+)-2-Hydroxy-n-butyric acid</synonym>
    <synonym>(+)-2-Hydroxybutanoic acid</synonym>
    <synonym>(+)-2-Hydroxybutyric acid</synonym>
    <synonym>(+)-alpha-Hydroxybutyric acid</synonym>
    <synonym>(+)-α-Hydroxybutyric acid</synonym>
    <synonym>(2S)-2-Hydroxybutanoic acid</synonym>
    <synonym>(S)-(+)-2-Hydroxybutanoic acid</synonym>
    <synonym>(S)-2-Hydroxybutyric acid</synonym>
    <synonym>2-Hydroxybutanoic acid</synonym>
    <synonym>alpha-Hydroxy-n-butyric acid</synonym>
    <synonym>alpha-Hydroxybutanoic acid</synonym>
    <synonym>alpha-Hydroxybutyric acid</synonym>
    <synonym>α-Hydroxy-n-butyric acid</synonym>
    <synonym>α-Hydroxybutanoic acid</synonym>
    <synonym>α-Hydroxybutyric acid</synonym>
  </synonyms>
  <chemical_formula>C4H8O3</chemical_formula>
  <average_molecular_weight>104.105</average_molecular_weight>
  <monisotopic_molecular_weight>104.047344118</monisotopic_molecular_weight>
  <iupac_name>(2S)-2-hydroxybutanoic acid</iupac_name>
  <traditional_iupac>(S)-2-hydroxybutyric acid</traditional_iupac>
  <cas_registry_number>3347-90-8</cas_registry_number>
  <smiles>CC[C@H](O)C(O)=O</smiles>
  <inchi>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1</inchi>
  <inchikey>AFENDNXGAFYKQO-VKHMYHEASA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon.</description>
    <direct_parent>Alpha hydroxy acids and derivatives</direct_parent>
    <kingdom>Organic compounds</kingdom>
    <super_class>Organic acids and derivatives</super_class>
    <class>Hydroxy acids and derivatives</class>
    <sub_class>Alpha hydroxy acids and derivatives</sub_class>
    <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
    <alternative_parents>
      <alternative_parent>Carbonyl compounds</alternative_parent>
      <alternative_parent>Carboxylic acids</alternative_parent>
      <alternative_parent>Fatty acids and conjugates</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
      <alternative_parent>Organic oxides</alternative_parent>
      <alternative_parent>Secondary alcohols</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>Alcohol</substituent>
      <substituent>Aliphatic acyclic compound</substituent>
      <substituent>Alpha-hydroxy acid</substituent>
      <substituent>Carbonyl group</substituent>
      <substituent>Carboxylic acid</substituent>
      <substituent>Carboxylic acid derivative</substituent>
      <substituent>Fatty acid</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>Monocarboxylic acid or derivatives</substituent>
      <substituent>Organic oxide</substituent>
      <substituent>Organic oxygen compound</substituent>
      <substituent>Organooxygen compound</substituent>
      <substituent>Secondary alcohol</substituent>
    </substituents>
    <external_descriptors>
      <external_descriptor>2-hydroxybutyric acid</external_descriptor>
      <external_descriptor>Hydroxy fatty acids</external_descriptor>
      <external_descriptor>Hydroxy fatty acids</external_descriptor>
    </external_descriptors>
  </taxonomy>
  <ontology>
    <root>
      <term>Physiological effect</term>
      <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Health effect</term>
          <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
          <parent_id>7693</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Health condition</term>
              <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Schizophrenia</term>
                  <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Pyruvate dehydrogenase deficiency</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Pdh</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Disposition</term>
      <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Source</term>
          <definition>Natural or synthetic origin of a chemical.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Endogenous</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological location</term>
          <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Tissue and substructures</term>
              <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Placenta</term>
                  <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Organ and components</term>
              <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Prostate</term>
                  <definition>The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Prostate gland</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biofluid and excreta</term>
              <definition>A liquid, semi-solid or solid material originating in the body.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Urine</term>
                  <definition>Excretion in liquid state processed by the kidney.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Saliva</term>
                  <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Feces</term>
                  <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fecal</synonym>
                    <synonym>Stool</synonym>
                    <synonym>Faecal</synonym>
                    <synonym>Faeces</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Blood</term>
                  <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Sweat</term>
                  <definition>Secretion produced by a sweat gland.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cerebrospinal fluid</term>
                  <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Csf</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Subcellular</term>
              <definition>An anatomical organizational level including a component within a biological cell .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cytoplasm</term>
                  <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Cytoplasma</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Cell and elements</term>
              <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Extracellular</term>
                  <definition>The space external to the outermost structure of a cell.</definition>
                  <parent_id>7732</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Extracellular region</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Process</term>
      <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Naturally occurring process</term>
          <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
          <parent_id>7659</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biological process</term>
              <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
              <parent_id>7660</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biochemical pathway</term>
                  <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                  <parent_id>7661</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Propanoate Metabolism</term>
                      <definition> alternatively, propionyl-coa results from the oxidative decarboxylation of 2-ketobutyric acid. this reaction is mediated by a large, multienzyme complex such as the branched-chain alpha-keto acid dehydrogenase complex.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Role</term>
      <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Biological role</term>
          <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
          <parent_id>7671</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Metabolite</term>
              <definition>A chemical substance produced during metabolism process, as an intermediate or end-product.</definition>
              <parent_id>7672</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
  </ontology>
  <state>Solid</state>
  <experimental_properties>
    <property>
      <kind>melting_point</kind>
      <value>44.2 °C</value>
      <source></source>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>-0.16</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>0.67</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>484 g/L</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>0.051</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>3.99</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>-3.8</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>(2S)-2-hydroxybutanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>104.105</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>104.047344118</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>CC[C@H](O)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C4H8O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>AFENDNXGAFYKQO-VKHMYHEASA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>57.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>23.36</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>9.98</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <spectra>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>2063</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102797</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102798</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102799</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102800</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102801</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102802</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>102803</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>159343</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5245</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5246</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5312</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5313</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5314</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5315</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5316</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5317</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5318</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5319</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5320</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5321</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5322</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5323</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5324</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5325</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5326</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5327</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5328</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5329</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5330</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5331</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1250182</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1250183</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1250184</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1365478</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1365479</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1365480</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1448541</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1448542</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1448543</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1448544</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1448545</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>1448546</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2253310</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2257260</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2257338</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2259269</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2259286</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2734025</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2734026</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2734027</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2971863</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2971864</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2971865</spectrum_id>
    </spectrum>
  </spectra>
  <biological_properties>
    <cellular_locations>
      <cellular>Cytoplasm</cellular>
      <cellular>Extracellular</cellular>
    </cellular_locations>
    <biospecimen_locations>
      <biospecimen>Blood</biospecimen>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <biospecimen>Feces</biospecimen>
      <biospecimen>Saliva</biospecimen>
      <biospecimen>Sweat</biospecimen>
      <biospecimen>Urine</biospecimen>
    </biospecimen_locations>
    <tissue_locations>
      <tissue>Placenta</tissue>
      <tissue>Prostate</tissue>
    </tissue_locations>
    <pathways>
      <pathway>
        <name>Malonic Aciduria</name>
        <smpdb_id>SMP00198</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Malonyl-coa decarboxylase deficiency</name>
        <smpdb_id>SMP00502</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Methylmalonic Aciduria Due to Cobalamin-Related Disorders</name>
        <smpdb_id>SMP00201</smpdb_id>
        <kegg_map_id/>
      </pathway>
      <pathway>
        <name>Propanoate metabolism</name>
        <smpdb_id/>
        <kegg_map_id>map00640</kegg_map_id>
      </pathway>
    </pathways>
  </biological_properties>
  <normal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>8.00-80.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Molecular You: https://molecularyou.com</reference_text>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>26.9(32.92)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
          <pubmed_id>26010610</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>8.00-80.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
          <pubmed_id>8412012</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>With wine consumption. Female twins. Healthy condition not specified, assume it is healthy</comment>
      <references>
        <reference>
          <reference_text>Pallister T, Jennings A, Mohney RP, Yarand D, Mangino M, Cassidy A, MacGregor A, Spector TD, Menni C: Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins. PLoS One. 2016 Jun 29;11(6):e0158568. doi: 10.1371/journal.pone.0158568. eCollection 2016.</reference_text>
          <pubmed_id>27355821</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>54.0 (8.0-80.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
          <pubmed_id>8412012</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>40.0 +/- 24.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
          <pubmed_id>18502700</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>85.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
          <pubmed_id>18502700</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>37 +/- 21 (10 - 76)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann GF, Seppel CK, Holmes B, Mitchell L, Christen HJ, Hanefeld F, Rating D, Nyhan WL: Quantitative organic acid analysis in cerebrospinal fluid and plasma: reference values in a pediatric population. J Chromatogr. 1993 Jul 23;617(1):1-10.</reference_text>
          <pubmed_id>8376520</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>35.0 +/- 24.0 </concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
          <pubmed_id>8412012</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
      <references>
        <reference>
          <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
          <pubmed_id>29808030</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
          <pubmed_id>27543620</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>10.42 +/- 9.20</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Sweat</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult </subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Delgado-Povedano MM, Calderon-Santiago M, Priego-Capote F, Luque de Castro MD: Development of a method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry in high resolution mode. Anal Chim Acta. 2016 Jan 28;905:115-25. doi: 10.1016/j.aca.2015.11.048. Epub 2015 Dec 17.</reference_text>
          <pubmed_id>26755145</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.31-0.69 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.445 (0-4.89)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Landaas S, Pettersen JE: Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid. Scand J Clin Lab Invest. 1975 May;35(3):259-66.</reference_text>
          <pubmed_id>168632</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0-3</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC/MS. Samples were collected from infants of 1-6 months old</comment>
      <references>
        <reference>
          <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
          <pubmed_id>31963255</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0-6.0</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC/MS. Samples were collected from infants of 7-12 months old</comment>
      <references>
        <reference>
          <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
          <pubmed_id>31963255</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0-6.1</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC/MS. Samples were collected from infants of 1-6 months old</comment>
      <references>
        <reference>
          <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
          <pubmed_id>31963255</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0-9.3</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC/MS. Samples were collected from infants of 7-12 months old</comment>
      <references>
        <reference>
          <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
          <pubmed_id>31963255</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3.29 +/- 3.529</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.8 (1.2-6.9)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>urine by NMR</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>5.0 (0.0-10.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.26-0.53 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
  </normal_concentrations>
  <abnormal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>26.96 +/- 13.11 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
      <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>16.93 +/- 8.17</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>21.4 (5.6) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Early preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>19.5 (7.4) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <references>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>17.13 (7.48) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetus having congenital heart defect</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>16.69 (6.25) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>28.0 (14.4) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Late-onset preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>4.14(10.18)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Heart failure with reduced ejection fraction</patient_information>
      <references>
        <reference>
          <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
          <pubmed_id>26010610</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>21.2 (7.5) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>23.1 (14.1) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Down syndrome pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>15.0 (7.4) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal Cancer</patient_information>
      <references>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <comment>Lyophilized feces samples (n=131) were used in the study. Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
      <references>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>7.26 +/- 4.47</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>7.30 +/- 1.32</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Frontotemporal lobe dementia</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>8.12 +/- 5.32</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Lewy body disease</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>&gt;25.0</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Pyruvate dehydrogenase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>OMIM 238331</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>8.699 +/- 10.366</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>248.732</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Dihydrolipoamide Dehydrogenase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Kuhara T, Shinka T, Inoue Y, Matsumoto M, Yoshino M, Sakaguchi Y, Matsumoto I: Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency. Clin Chim Acta. 1983 Sep 30;133(2):133-40.</reference_text>
          <pubmed_id>6688766</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal adenoma </patient_information>
      <comment>With shellfish consumption</comment>
      <references>
        <reference>
          <reference_text>Playdon MC, Sampson JN, Cross AJ, Sinha R, Guertin KA, Moy KA, Rothman N, Irwin ML, Mayne ST, Stolzenberg-Solomon R, Moore SC: Comparing metabolite profiles of habitual diet in serum and urine. Am J Clin Nutr. 2016 Sep;104(3):776-89. doi: 10.3945/ajcn.116.135301. Epub 2016 Aug 10.</reference_text>
          <pubmed_id>27510537</pubmed_id>
        </reference>
      </references>
    </concentration>
  </abnormal_concentrations>
  <diseases>
    <disease>
      <name>Colorectal cancer</name>
      <omim_id>114500</omim_id>
      <references>
        <reference>
          <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
          <pubmed_id>7482520</pubmed_id>
        </reference>
        <reference>
          <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
          <pubmed_id>19006102</pubmed_id>
        </reference>
        <reference>
          <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
          <pubmed_id>23940645</pubmed_id>
        </reference>
        <reference>
          <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
          <pubmed_id>24424155</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
          <pubmed_id>20156336</pubmed_id>
        </reference>
        <reference>
          <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
          <pubmed_id>19678709</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
          <pubmed_id>22148915</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
          <pubmed_id>21773981</pubmed_id>
        </reference>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
          <pubmed_id>27107423</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
          <pubmed_id>28587349</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Schizophrenia</name>
      <omim_id>181500</omim_id>
      <references>
        <reference>
          <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
          <pubmed_id>115032</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
          <pubmed_id>7126379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
          <pubmed_id>2480613</pubmed_id>
        </reference>
        <reference>
          <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
          <pubmed_id>17276036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
          <pubmed_id>11877547</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
          <pubmed_id>12796220</pubmed_id>
        </reference>
        <reference>
          <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
          <pubmed_id>7595563</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
          <pubmed_id>20814316</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
        <reference>
          <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
          <pubmed_id>24713860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
          <pubmed_id>23823132</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
          <pubmed_id>2415198</pubmed_id>
        </reference>
        <reference>
          <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
          <pubmed_id>1694425</pubmed_id>
        </reference>
        <reference>
          <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
          <pubmed_id>7711000</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
          <pubmed_id>19390223</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
        <reference>
          <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
          <pubmed_id>22007635</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
          <pubmed_id>21483431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
          <pubmed_id>3741918</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
          <pubmed_id>11979513</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
          <pubmed_id>20206656</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
          <pubmed_id>436860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
          <pubmed_id>19401681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
          <pubmed_id>6184954</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
          <pubmed_id>26952797</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
        <reference>
          <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
          <pubmed_id>24789758</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
          <pubmed_id>22944140</pubmed_id>
        </reference>
        <reference>
          <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
          <pubmed_id>22892715</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
          <pubmed_id>17440431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
          <pubmed_id>25729574</pubmed_id>
        </reference>
        <reference>
          <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
          <pubmed_id>22257447</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Early preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pregnancy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
          <pubmed_id>3252730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
          <pubmed_id>663967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
          <pubmed_id>12833386</pubmed_id>
        </reference>
        <reference>
          <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
          <pubmed_id>2994907</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
          <pubmed_id>17704099</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
          <pubmed_id>12698507</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
          <pubmed_id>17061063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
          <pubmed_id>16925883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
          <pubmed_id>22420377</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
          <pubmed_id>18059417</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
        <reference>
          <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Late-onset preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Alzheimer's disease</name>
      <omim_id>104300</omim_id>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
        <reference>
          <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
          <pubmed_id>11959400</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
          <pubmed_id>8595727</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
          <pubmed_id>15361288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
          <pubmed_id>15465626</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
          <pubmed_id>15061359</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
          <pubmed_id>10494443</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
          <pubmed_id>11255442</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
          <pubmed_id>12498967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
          <pubmed_id>16227558</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
          <pubmed_id>9720975</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
          <pubmed_id>12111441</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
          <pubmed_id>16244393</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
          <pubmed_id>8356878</pubmed_id>
        </reference>
        <reference>
          <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
          <pubmed_id>12391605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
          <pubmed_id>8478958</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
          <pubmed_id>21292280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
          <pubmed_id>20858978</pubmed_id>
        </reference>
        <reference>
          <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
          <pubmed_id>21474939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
          <pubmed_id>20523031</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
          <pubmed_id>11314776</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
          <pubmed_id>1716470</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Frontotemporal dementia</name>
      <omim_id>600274</omim_id>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Lewy body disease</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pyruvate dehydrogenase deficiency</name>
      <omim_id>312170</omim_id>
      <references>
        <reference>
          <reference_text>Patel KP, O'Brien TW, Subramony SH, Shuster J, Stacpoole PW: The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab. 2012 Jan;105(1):34-43. doi: 10.1016/j.ymgme.2011.09.032. Epub 2011 Oct 7.</reference_text>
          <pubmed_id>22079328</pubmed_id>
        </reference>
        <reference>
          <reference_text>OMIM 238331</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Eosinophilic esophagitis</name>
      <omim_id>610247</omim_id>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Dihydrolipoamide Dehydrogenase Deficiency</name>
      <omim_id>246900</omim_id>
      <references>
        <reference>
          <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
          <pubmed_id>11978597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kuhara T, Shinka T, Inoue Y, Matsumoto M, Yoshino M, Sakaguchi Y, Matsumoto I: Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency. Clin Chim Acta. 1983 Sep 30;133(2):133-40.</reference_text>
          <pubmed_id>6688766</pubmed_id>
        </reference>
      </references>
    </disease>
  </diseases>
  <foodb_id>FDB021867</foodb_id>
  <kegg_id>C05984</kegg_id>
  <chemspider_id>389701</chemspider_id>
  <chebi_id>50613</chebi_id>
  <pubchem_compound_id>440864</pubchem_compound_id>
  <pdb_id/>
  <biocyc_id>CPD-3564</biocyc_id>
  <drugbank_id/>
  <phenol_explorer_compound_id/>
  <wikipedia_id>2-Hydroxybutyric_acid</wikipedia_id>
  <knapsack_id/>
  <bigg_id/>
  <metlin_id/>
  <vmh_id/>
  <synthesis_reference>Carlier, J. P.; Henry, C.; Lorin, V.; Rouffignat, K. Conversion of DL-threonine, D-threonine and 2-oxobutyrate into propionate and 2-hydroxybutyrate by Fusobacterium species. Letters in Applied Microbiology  (1997),  25(5),  371-374.  </synthesis_reference>
  <general_references>
    <reference>
      <reference_text>Sweatman BC, Farrant RD, Holmes E, Ghauri FY, Nicholson JK, Lindon JC: 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal. 1993 Aug;11(8):651-64.</reference_text>
      <pubmed_id>8257730</pubmed_id>
    </reference>
    <reference>
      <reference_text>Landaas S, Pettersen JE: Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid. Scand J Clin Lab Invest. 1975 May;35(3):259-66.</reference_text>
      <pubmed_id>168632</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.</reference_text>
      <pubmed_id>19212411</pubmed_id>
    </reference>
    <reference>
      <reference_text>Li X, Xu Z, Lu X, Yang X, Yin P, Kong H, Yu Y, Xu G: Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta. 2009 Feb 9;633(2):257-62. doi: 10.1016/j.aca.2008.11.058. Epub 2008 Dec 3.</reference_text>
      <pubmed_id>19166731</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E: alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One. 2010 May 28;5(5):e10883. doi: 10.1371/journal.pone.0010883.</reference_text>
      <pubmed_id>20526369</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
      <pubmed_id>32033212</pubmed_id>
    </reference>
    <reference>
      <reference_text>Aldrich Library of FT-IR Spectra, 1st edn., 1985, 1, 548D</reference_text>
    </reference>
    <reference>
      <reference_text>Mori, K. et al., Tetrahedron, 1979, 35, 1601</reference_text>
    </reference>
    <reference>
      <reference_text>Levene, P.A. et al., J. Biol. Chem., 1941, 141, 391</reference_text>
    </reference>
    <reference>
      <reference_text>Duvillier, E., Ann. Chim. Phys., 1879, 17, 532</reference_text>
    </reference>
    <reference>
      <reference_text>Chenault, H.K. et al., J.O.C., 1987, 52, 2608</reference_text>
    </reference>
    <reference>
      <reference_text>Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 1, 854B</reference_text>
    </reference>
    <reference>
      <reference_text>Horn, D.H.S. et al., J.C.S., 1954, 1460</reference_text>
    </reference>
    <reference>
      <reference_text>Wong, C.H. et al., J.O.C., 1985, 50, 1992</reference_text>
    </reference>
  </general_references>
  <protein_associations>
    <protein>
      <protein_accession>HMDBP00054</protein_accession>
      <name>Dihydrolipoyl dehydrogenase, mitochondrial</name>
      <uniprot_id>P09622</uniprot_id>
      <gene_name>DLD</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00355</protein_accession>
      <name>Sulfotransferase family cytosolic 2B member 1</name>
      <uniprot_id>O00204</uniprot_id>
      <gene_name>SULT2B1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00483</protein_accession>
      <name>UDP-glucuronosyltransferase 1-1</name>
      <uniprot_id>P22309</uniprot_id>
      <gene_name>UGT1A1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00893</protein_accession>
      <name>L-lactate dehydrogenase A-like 6A</name>
      <uniprot_id>Q6ZMR3</uniprot_id>
      <gene_name>LDHAL6A</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03577</protein_accession>
      <name>L-lactate dehydrogenase B chain</name>
      <uniprot_id>P07195</uniprot_id>
      <gene_name>LDHB</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03578</protein_accession>
      <name>L-lactate dehydrogenase C chain</name>
      <uniprot_id>P07864</uniprot_id>
      <gene_name>LDHC</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03579</protein_accession>
      <name>L-lactate dehydrogenase A chain</name>
      <uniprot_id>P00338</uniprot_id>
      <gene_name>LDHA</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP03581</protein_accession>
      <name>L-lactate dehydrogenase A-like 6B</name>
      <uniprot_id>Q9BYZ2</uniprot_id>
      <gene_name>LDHAL6B</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
  </protein_associations>
</metabolite>
<metabolite>
  <version>5.0</version>
  <creation_date>2005-11-16 15:48:42 UTC</creation_date>
  <update_date>2021-09-14 15:00:08 UTC</update_date>
  <accession>HMDB0000011</accession>
  <status>quantified</status>
  <secondary_accessions>
    <accession>HMDB0000357</accession>
    <accession>HMDB00011</accession>
    <accession>HMDB00357</accession>
  </secondary_accessions>
  <name>3-Hydroxybutyric acid</name>
  <description>3-Hydroxybutyric acid (CAS: 300-85-6), also known as beta-hydroxybutanoic acid, is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis. This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of 3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid, and is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for the synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for the synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmitoylphosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. 3-Hydroxybutyric acid is a metabolite of Alcaligenes and can be produced from plastic metabolization or incorporated into polymers, depending on the species (PMID: 7646009, 18615882).</description>
  <synonyms>
    <synonym>(R)-(-)-beta-Hydroxybutyric acid</synonym>
    <synonym>(R)-3-Hydroxybutanoic acid</synonym>
    <synonym>3-D-Hydroxybutyric acid</synonym>
    <synonym>D-3-Hydroxybutyric acid</synonym>
    <synonym>D-beta-Hydroxybutyric acid</synonym>
    <synonym>(R)-(-)-b-Hydroxybutyrate</synonym>
    <synonym>(R)-(-)-b-Hydroxybutyric acid</synonym>
    <synonym>(R)-(-)-beta-Hydroxybutyrate</synonym>
    <synonym>(R)-(-)-Β-hydroxybutyrate</synonym>
    <synonym>(R)-(-)-Β-hydroxybutyric acid</synonym>
    <synonym>(R)-3-Hydroxybutanoate</synonym>
    <synonym>3-D-Hydroxybutyrate</synonym>
    <synonym>D-3-Hydroxybutyrate</synonym>
    <synonym>D-b-Hydroxybutyrate</synonym>
    <synonym>D-b-Hydroxybutyric acid</synonym>
    <synonym>D-beta-Hydroxybutyrate</synonym>
    <synonym>D-Β-hydroxybutyrate</synonym>
    <synonym>D-Β-hydroxybutyric acid</synonym>
    <synonym>(R)-3-Hydroxybutyrate</synonym>
    <synonym>3-delta-Hydroxybutyrate</synonym>
    <synonym>3-delta-Hydroxybutyric acid</synonym>
    <synonym>BHIB</synonym>
    <synonym>D-(-)-3-Hydroxybutyrate</synonym>
    <synonym>delta-(-)-3-Hydroxybutyrate</synonym>
    <synonym>delta-3-Hydroxybutyrate</synonym>
    <synonym>delta-3-Hydroxybutyric acid</synonym>
    <synonym>delta-beta-Hydroxybutyrate</synonym>
    <synonym>3R-Hydroxy-butanoate</synonym>
    <synonym>(R)-3-Hydroxybutyric acid</synonym>
    <synonym>(-)-3-Hydroxy-n-butyric acid</synonym>
    <synonym>(-)-3-Hydroxybutyric acid</synonym>
    <synonym>(3R)-3-Hydroxybutanoic acid</synonym>
    <synonym>(3R)-3-Hydroxybutyric acid</synonym>
    <synonym>(3R)-Hydroxybutyrate</synonym>
    <synonym>(R)-(-)-3-Hydroxybutyric acid</synonym>
    <synonym>(R)-beta-Hydroxybutanoic acid</synonym>
    <synonym>(R)-beta-Hydroxybutyric acid</synonym>
    <synonym>(R)-β-Hydroxybutanoic acid</synonym>
    <synonym>(R)-β-Hydroxybutyric acid</synonym>
    <synonym>3-Hydroxy-n-butyric acid</synonym>
    <synonym>3-Hydroxybutanoic acid</synonym>
    <synonym>3-Hydroxybutyric acid</synonym>
    <synonym>3R-Hydroxybutanoic acid</synonym>
    <synonym>D-(-)-3-Hydroxybutanoic acid</synonym>
    <synonym>D-(-)-3-Hydroxybutyric acid</synonym>
    <synonym>D-(-)-beta-Hydroxybutyric acid</synonym>
    <synonym>D-(-)-β-Hydroxybutyric acid</synonym>
    <synonym>beta-Hydroxy-n-butyric acid</synonym>
    <synonym>beta-Hydroxybutanoic acid</synonym>
    <synonym>beta-Hydroxybutyric acid</synonym>
    <synonym>β-Hydroxy-n-butyric acid</synonym>
    <synonym>β-Hydroxybutanoic acid</synonym>
    <synonym>β-Hydroxybutyric acid</synonym>
  </synonyms>
  <chemical_formula>C4H8O3</chemical_formula>
  <average_molecular_weight>104.1045</average_molecular_weight>
  <monisotopic_molecular_weight>104.047344122</monisotopic_molecular_weight>
  <iupac_name>(3R)-3-hydroxybutanoic acid</iupac_name>
  <traditional_iupac>(-)-3-hydroxybutyric acid</traditional_iupac>
  <cas_registry_number>625-72-9</cas_registry_number>
  <smiles>C[C@@H](O)CC(O)=O</smiles>
  <inchi>InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1</inchi>
  <inchikey>WHBMMWSBFZVSSR-GSVOUGTGSA-N</inchikey>
  <taxonomy>
    <description> belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom.</description>
    <direct_parent>Beta hydroxy acids and derivatives</direct_parent>
    <kingdom>Organic compounds</kingdom>
    <super_class>Organic acids and derivatives</super_class>
    <class>Hydroxy acids and derivatives</class>
    <sub_class>Beta hydroxy acids and derivatives</sub_class>
    <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
    <alternative_parents>
      <alternative_parent>Carbonyl compounds</alternative_parent>
      <alternative_parent>Carboxylic acids</alternative_parent>
      <alternative_parent>Fatty acids and conjugates</alternative_parent>
      <alternative_parent>Hydrocarbon derivatives</alternative_parent>
      <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
      <alternative_parent>Organic oxides</alternative_parent>
      <alternative_parent>Secondary alcohols</alternative_parent>
      <alternative_parent>Short-chain hydroxy acids and derivatives</alternative_parent>
    </alternative_parents>
    <substituents>
      <substituent>Alcohol</substituent>
      <substituent>Aliphatic acyclic compound</substituent>
      <substituent>Beta-hydroxy acid</substituent>
      <substituent>Carbonyl group</substituent>
      <substituent>Carboxylic acid</substituent>
      <substituent>Carboxylic acid derivative</substituent>
      <substituent>Fatty acid</substituent>
      <substituent>Hydrocarbon derivative</substituent>
      <substituent>Monocarboxylic acid or derivatives</substituent>
      <substituent>Organic oxide</substituent>
      <substituent>Organic oxygen compound</substituent>
      <substituent>Organooxygen compound</substituent>
      <substituent>Secondary alcohol</substituent>
      <substituent>Short-chain hydroxy acid</substituent>
    </substituents>
    <external_descriptors>
      <external_descriptor>3-hydroxybutyric acid</external_descriptor>
      <external_descriptor>Hydroxy fatty acids</external_descriptor>
      <external_descriptor>ketone body</external_descriptor>
    </external_descriptors>
  </taxonomy>
  <ontology>
    <root>
      <term>Physiological effect</term>
      <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Health effect</term>
          <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
          <parent_id>7693</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Health condition</term>
              <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
              <parent_id>7694</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Diabetes mellitus type 2</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Non-insulin-dependent diabetes mellitus</synonym>
                    <synonym>Niddm</synonym>
                    <synonym>Adult-onset diabetes</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Schizophrenia</term>
                  <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Anoxia</term>
                  <definition/>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Metabolism and nutrition disorders</term>
                  <definition>A group of disorders, inherited or not, that result in a metabolic malfunction.</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Obesity</term>
                      <definition>A disorder characterized by having a high amount of body fat. (nci ctcae).</definition>
                      <parent_id>7708</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Infections and infestations</term>
                  <definition>Any  disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. it can be transmitted by direct or indirect contact. (nci).</definition>
                  <parent_id>7695</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Meningitis</term>
                      <definition>A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord. (nci ctcae).</definition>
                      <parent_id>7713</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Disposition</term>
      <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Source</term>
          <definition>Natural or synthetic origin of a chemical.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Endogenous</term>
              <definition/>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>child</type>
              <synonyms>
              </synonyms>
            </descendant>
            <descendant>
              <term>Biological</term>
              <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
              <parent_id>7735</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Microbe</term>
                  <definition>A living organism that is of a microscopic scale, either single-celled or a cluster of cells.</definition>
                  <parent_id>7736</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Alcaligenes</term>
                      <definition/>
                      <parent_id>7739</parent_id>
                      <level>5</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Alcaligenes eutrophus</term>
                          <definition/>
                          <parent_id>11250</parent_id>
                          <level>6</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
        <descendant>
          <term>Biological location</term>
          <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
          <parent_id>7724</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Tissue and substructures</term>
              <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Placenta</term>
                  <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                  <parent_id>7729</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Organ and components</term>
              <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Brain</term>
                  <definition>An organ composed of grey and white matter that is the center for intelligence and reasoning. it is protected by the bony cranium. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Liver</term>
                  <definition>An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. (nci).</definition>
                  <parent_id>7727</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biofluid and excreta</term>
              <definition>A liquid, semi-solid or solid material originating in the body.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Urine</term>
                  <definition>Excretion in liquid state processed by the kidney.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Blood</term>
                  <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cerebrospinal fluid</term>
                  <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Csf</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Saliva</term>
                  <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Feces</term>
                  <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                  <parent_id>7731</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Fecal</synonym>
                    <synonym>Stool</synonym>
                    <synonym>Faecal</synonym>
                    <synonym>Faeces</synonym>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Subcellular</term>
              <definition>An anatomical organizational level including a component within a biological cell .</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cytoplasm</term>
                  <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Cytoplasma</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Mitochondria</term>
                  <definition/>
                  <parent_id>7730</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Cell and elements</term>
              <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
              <parent_id>7725</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Extracellular</term>
                  <definition>The space external to the outermost structure of a cell.</definition>
                  <parent_id>7732</parent_id>
                  <level>4</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Extracellular region</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Cell</term>
                  <definition/>
                  <parent_id>7732</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Nerve cell</term>
                      <definition>A cell in the nervous system, that is able to conduct weak electric signals between the brain and the body. A typical neuron consists of a cell body, containing the nucleus and the surrounding cytoplasm (perikaryon); several short radiating processes (dendrites); and one long process (the axon), which terminates in twiglike branches (telodendrons) and may have branches (collaterals) projecting along its course. (NCI).</definition>
                      <parent_id>7734</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Neuron</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
    <root>
      <term>Process</term>
      <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
      <parent_id/>
      <level>1</level>
      <type>parent</type>
      <descendants>
        <descendant>
          <term>Naturally occurring process</term>
          <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
          <parent_id>7659</parent_id>
          <level>2</level>
          <type>parent</type>
          <synonyms>
          </synonyms>
          <descendants>
            <descendant>
              <term>Biological process</term>
              <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
              <parent_id>7660</parent_id>
              <level>3</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biochemical pathway</term>
                  <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                  <parent_id>7661</parent_id>
                  <level>4</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ketone Body Metabolism</term>
                      <definition> the first two are synthesized from acetyl-coa, in the mitochondria of liver cells; acetone is formed by spontaneous decarboxylation of acetoacetate. ketone body synthesis (ketogenesis) in liver is effectively irreversible because the enzyme that catalyzes the conversion of acetoacetate to acetoacetyl-coa is not present in liver cells.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Fatty Acid Biosynthesis</term>
                      <definition> the entire synthesis process which produces palmitic acid occurs on a multifunctional dimeric protein fatty acid synthase (fa) in the cytosol. the production of palmitic acid can be summarized as the successive addition of two carbons to an initial acetyl moiety primer.</definition>
                      <parent_id>7662</parent_id>
                      <level>5</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </descendant>
      </descendants>
    </root>
  </ontology>
  <state>Solid</state>
  <experimental_properties>
    <property>
      <kind>melting_point</kind>
      <value>49 - 50 °C</value>
      <source></source>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>-0.50</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logs</kind>
      <value>0.71</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>solubility</kind>
      <value>539 g/L</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logp</kind>
      <value>-0.39</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>4.41</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_basic</kind>
      <value>-2.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>(3R)-3-hydroxybutanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>104.1045</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>104.047344122</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>C[C@@H](O)CC(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>C4H8O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>WHBMMWSBFZVSSR-GSVOUGTGSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>57.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>23.46</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>9.96</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>number_of_rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>bioavailability</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rule_of_five</kind>
      <value>Yes</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>ghose_filter</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>veber_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mddr_like_rule</kind>
      <value>No</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <spectra>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>26212</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>30136</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>37241</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>99520</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>133294</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::CMs</type>
      <spectrum_id>141028</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::EiMs</type>
      <spectrum_id>2010</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrTwoD</type>
      <spectrum_id>920</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>1027</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5332</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5333</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5334</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5335</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5336</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5337</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5338</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5339</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5340</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5341</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5342</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5343</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5344</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5345</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5346</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5347</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5348</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5349</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5350</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::NmrOneD</type>
      <spectrum_id>5351</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>16</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>17</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>18</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2526</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2527</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2528</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2529</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2530</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>324085</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>324086</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>324087</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>372409</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>372410</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>372411</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437816</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437817</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437818</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437819</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>437820</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>440114</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2233646</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2252490</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2253978</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2254601</spectrum_id>
    </spectrum>
    <spectrum>
      <type>Specdb::MsMs</type>
      <spectrum_id>2255993</spectrum_id>
    </spectrum>
  </spectra>
  <biological_properties>
    <cellular_locations>
      <cellular>Cytoplasm</cellular>
      <cellular>Extracellular</cellular>
      <cellular>Mitochondria</cellular>
    </cellular_locations>
    <biospecimen_locations>
      <biospecimen>Blood</biospecimen>
      <biospecimen>Cellular Cytoplasm</biospecimen>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <biospecimen>Feces</biospecimen>
      <biospecimen>Saliva</biospecimen>
      <biospecimen>Urine</biospecimen>
    </biospecimen_locations>
    <tissue_locations>
    </tissue_locations>
    <pathways>
      <pathway>
        <name>Fatty Acid Biosynthesis</name>
        <smpdb_id>SMP00456</smpdb_id>
        <kegg_map_id></kegg_map_id>
      </pathway>
      <pathway>
        <name>Ketone Body Metabolism</name>
        <smpdb_id>SMP00071</smpdb_id>
        <kegg_map_id>map00072</kegg_map_id>
      </pathway>
      <pathway>
        <name>Succinyl CoA: 3-ketoacid CoA transferase deficiency</name>
        <smpdb_id>SMP00569</smpdb_id>
        <kegg_map_id/>
      </pathway>
    </pathways>
  </biological_properties>
  <normal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>60.0 +/- 20.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ: Increased postprandial triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 Mar;38(3):527-33.</reference_text>
          <pubmed_id>16540841</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>40.0 +/- 10.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ: Increased postprandial triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 Mar;38(3):527-33.</reference_text>
          <pubmed_id>16540841</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>323.0 +/- 29.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
          <pubmed_id>16253646</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>36 +/- 20</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hansen JL, Freier EF: Direct assays of lactate, pyruvate, beta-hydroxybutyrate, and acetoacetate with a centrifugal analyzer. Clin Chem. 1978 Mar;24(3):475-9.</reference_text>
          <pubmed_id>415828</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>86 +/- 53</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Ozand PT, Hawkins RL, Collins RM Jr, Tildon JT, Cornblath M: A micro-autoanalytic procedure developed for the determination of ketone bodies, gluconeogenic amino acids, pyruvate, lactate, and glucose in metabolic studies. Biochem Med. 1975 Oct;14(2):170-83.</reference_text>
          <pubmed_id>1220702</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>38 +/- 31</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wildenhoff KE: Diurnal variations in the concentrations of blood acetoacetate, 3-hydroxybutyrate and glucose in normal persons. Acta Med Scand. 1972 Apr;191(4):303-6.</reference_text>
          <pubmed_id>5032673</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detcted by 1H NMR</comment>
      <references>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;500</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Robinson BH, Sherwood WG: Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res. 1975 Dec;9(12):935-9. doi: 10.1203/00006450-197512000-00015.</reference_text>
          <pubmed_id>172850</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>260-5040</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>n=7</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>50.0 (0.0-100.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Darzy KH, Murray RD, Gleeson HK, Pezzoli SS, Thorner MO, Shalet SM: The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J Clin Endocrinol Metab. 2006 Mar;91(3):987-94. Epub 2005 Dec 29.</reference_text>
          <pubmed_id>16384844</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>46.5 +/- 10.1</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by HPLC</comment>
      <references>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;600</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
          <pubmed_id>23430856</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;150</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
          <pubmed_id>12072887</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>100.0 +/- 90.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jovanovic L, Metzger BE, Knopp RH, conley MR, Park E, Lee YJ, Simpson JL, Holmes L, Aarons JH, Mills JL: The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development. Diabetes Care. 1998 Nov;21(11):1978-84.</reference_text>
          <pubmed_id>9802754</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>565.0 +/- 255.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>36.0 (13.0-95.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>80-3600</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
          <pubmed_id>8295396</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>64.88(60.4)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
          <pubmed_id>26010610</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>200 +/- 120</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Evening.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>170 +/- 110</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Morning.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>10.60-143.2</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>500-3000</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>After ingestion of medium-chain triglycerides.</comment>
      <references>
        <reference>
          <reference_text>Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA: Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997 Oct 23;337(17):1203-7. doi: 10.1056/NEJM199710233371704.</reference_text>
          <pubmed_id>9337379</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR </comment>
      <references>
        <reference>
          <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
          <pubmed_id>21505807</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>76.9 +/- 66.3</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>180.0 (22.0-700.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
          <pubmed_id>8412012</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cellular Cytoplasm</biospecimen>
      <concentration_value>1300 (1200-1400)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
          <pubmed_id>8579834</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>34 +/- 31</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
          <pubmed_id>18502700</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>50.0 (4.0 - 96.0)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>286 (207-365)</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
          <pubmed_id>15627241</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>46.4 +/- 23.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>48.0 +/- 48.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
          <pubmed_id>8412012</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
      <references>
        <reference>
          <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
          <pubmed_id>29808030</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Barrios C, Spector TD, Menni C: Blood, urine and faecal metabolite profiles in the study of adult renal disease. Arch Biochem Biophys. 2016 Jan 1;589:81-92. doi: 10.1016/j.abb.2015.10.006. Epub  2015 Oct 21.</reference_text>
          <pubmed_id>26476344</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-TOFMS on lyophilized fecal samples</comment>
      <references>
        <reference>
          <reference_text>Phua LC, Koh PK, Cheah PY, Ho HK, Chan EC: Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:103-13. doi: 10.1016/j.jchromb.2013.08.025. Epub 2013 Aug 26.</reference_text>
          <pubmed_id>24029555</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value>22.0932 +/- 9.606</concentration_value>
      <concentration_units>nmol/g wet feces</concentration_units>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-MS on fecal extract. The original unit of the concentration was reported as ug/mL. The concentration has been converted to nmol/g using the assumption that 1 mL = 1 g of feces.</comment>
      <references>
        <reference>
          <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
          <pubmed_id>20669995</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Wet feces samples (n=183) were used in the study.  Instrument: GC-MS.</comment>
      <references>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Not Specified</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>GC-MS on fecal extract</comment>
      <references>
        <reference>
          <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
          <pubmed_id>20669995</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>5.00 +/- 4.25</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>BMI &lt; 21.00 kg/m2 (n=45)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.</reference_text>
          <pubmed_id>12097436</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>2.64 +/- 1.83</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected at 16:00 (n=27)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Organic acid. By GC-MS.</comment>
      <references>
        <reference>
          <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>3.22 +/- 2.77</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>BMI ≥ 21.00 kg/m2 (n=22)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>3.88 +/- 4.26</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>16.44 +/- 19.52</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
      <references>
        <reference>
          <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
          <pubmed_id>22308371</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>4.71 +/- 7.21</concentration_value>
      <concentration_units>uM</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Saliva samples were collected at 16:00 (n=24)</comment>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.5-9.8</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By H-NMR 600 MHz BRUKER spectrometers</comment>
      <references>
        <reference>
          <reference_text>Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Anso S, Echevarria LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MA, Legorburu AP, Fang F, Astigarraga I, Schafer H, Spraul M, Millet O: NMR-based newborn urine screening for optimized detection of inherited errors of metabolism. Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.</reference_text>
          <pubmed_id>31506554</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>&lt;99</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
          <pubmed_id>28649521</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.4-2.7 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>&lt;54.301</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
          <pubmed_id>26078636</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>180.280 +/- 115.119</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>&lt;8 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>27.151 +/- 14.118</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>12 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>272.592 +/- 419.205</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>18 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3.4</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3397.0835 +/- 5584.336</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>30 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>616.862 +/- 982.852</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>24 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7-120</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Gregersen N, Kolvraa S, Rasmussen K, Mortensen PB, Divry P, David M, Hobolth N: General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.</reference_text>
          <pubmed_id>6616873</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7569.588 +/- 3599.0840</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>36 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.72-23.3</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>4.02(0.78-12.39)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3.14(0.71-23.84)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.60 +/- 3.50</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
          <pubmed_id>2026685</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>27.151 +/- 14.118</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>12-h Fast</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>272.592 +/- 419.205</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>18-h Fast</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>636.410 +/- 982.852</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>24-h Fast</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>6.651 +/- 7.809</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>180.4 +/- 115.00</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3397.0835 +/- 5584.336</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>30-h Fast</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>7569.588 +/- 3599.0840</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>36-h Fast</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>13.0 (1.0-27.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.4 +/- 1.3</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Jones MG, Cooper E, Amjad S, Goodwin CS, Barron JL, Chalmers RA: Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin Chim Acta. 2005 Nov;361(1-2):150-8.</reference_text>
          <pubmed_id>15992788</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.7 (0-2.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan WL, Sweetman L: Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin Chem. 1989 Apr;35(4):587-95.</reference_text>
          <pubmed_id>2702744</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>&lt;21.17</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GCMS.</comment>
      <references>
        <reference>
          <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>38.9 +/- 13.9</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Individuals were fasted for 8-12 hours'</comment>
      <references>
        <reference>
          <reference_text>Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET: Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008 Mar;21(3):195-207.</reference_text>
          <pubmed_id>17474139</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>32.3 +/- 8.7</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Individuals were fasted for 8-12 hours</comment>
      <references>
        <reference>
          <reference_text>Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET: Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008 Mar;21(3):195-207.</reference_text>
          <pubmed_id>17474139</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>48.0 (0.00-200.0)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.4-2.2 </concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Male</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
          <pubmed_id>27012787</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3.6 (1.3-6.4)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>urine by NMR</comment>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.257  +/-  1.254</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-MS Hewlett-Packard HP-5890 Series</comment>
      <references>
        <reference>
          <reference_text>Chu CY, Xiao X, Zhou XG, Lau TK, Rogers MS, Fok TF, Law LK, Pang CP, Wang CC: Metabolomic and bioinformatic analyses in asphyxiated neonates. Clin Biochem. 2006 Mar;39(3):203-9. doi: 10.1016/j.clinbiochem.2006.01.006. Epub  2006 Feb 7.</reference_text>
          <pubmed_id>16460720</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.0 (0.5-9.8)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Newborn (0-30 days old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
          <pubmed_id>8087979</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.4 (0.1-2.7)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1-13 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
          <pubmed_id>8087979</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>1.3 (0.1-5.8)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adolescent (13-18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
          <pubmed_id>8087979</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>29.712 +/- 14.532</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Children (1 - 13 years old)</subject_age>
      <subject_sex>Not Specified</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>By GC-MS</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>0.62 (0.0-12.09)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Raknes G, Aronsen L, Fuskevag OM: Urinary concentrations of gamma-hydroxybutyric acid and related compounds in pregnancy. J Anal Toxicol. 2010 Sep;34(7):394-9.</reference_text>
          <pubmed_id>20822677</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.24 (0.0-17.6)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Female</subject_sex>
      <subject_condition>Normal</subject_condition>
      <comment>Pregnant woman </comment>
      <references>
        <reference>
          <reference_text>Raknes G, Aronsen L, Fuskevag OM: Urinary concentrations of gamma-hydroxybutyric acid and related compounds in pregnancy. J Anal Toxicol. 2010 Sep;34(7):394-9.</reference_text>
          <pubmed_id>20822677</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3.6 (1.3-6.4)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Adult (&gt;18 years old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
          <pubmed_id>24023812</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>2.0 (0.6-5.6)</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <subject_age>Infant (0-1 year old)</subject_age>
      <subject_sex>Both</subject_sex>
      <subject_condition>Normal</subject_condition>
      <references>
        <reference>
          <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
          <pubmed_id>8087979</pubmed_id>
        </reference>
      </references>
    </concentration>
  </normal_concentrations>
  <abnormal_concentrations>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>235.0 +/- 17.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Obesity</patient_information>
      <references>
        <reference>
          <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
          <pubmed_id>16253646</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>35.1 +/- 33.9</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Heart Transplant</patient_information>
      <references>
        <reference>
          <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
          <pubmed_id>21359215</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>62.7 (85.0) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Down syndrome pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>21.0 (19.4) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>500</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=1. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>660</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adolescent (13-18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=1. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>200-2800</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=3. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>770-2900</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <comment>n=3. Fasting.</comment>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Oesophageal cancer</patient_information>
      <comment>By NMR and LC-MS </comment>
      <references>
        <reference>
          <reference_text>Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z, Raftery D: Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One. 2012;7(1):e30181. doi: 10.1371/journal.pone.0030181. Epub 2012 Jan 23.</reference_text>
          <pubmed_id>22291914</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by 1H NMR</comment>
      <references>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>220</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Very long-chain acyl-CoA dehydrogenase deficiency (vLCAD)</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>80-200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency</patient_information>
      <comment>n=2</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>700-1340</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium chain acyl-CoA dehydrogenase deficiency (MCAD)</patient_information>
      <comment>n=3</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1800</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Pyruvate dehydrogenase phosphatase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Robinson BH, Sherwood WG: Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res. 1975 Dec;9(12):935-9. doi: 10.1203/00006450-197512000-00015.</reference_text>
          <pubmed_id>172850</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>&lt;100</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Carnitine palmitoyltransferase deficiency I</patient_information>
      <references>
        <reference>
          <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
          <pubmed_id>11286380</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1500.0 +/- 100.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>Without diabetic ketoacidosis</comment>
      <references>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>0-380</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency</patient_information>
      <comment>n=5. Patients have hyperinsulinism.</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1490-5040</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Ketotic hypoglycemia</patient_information>
      <comment>n=5</comment>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>10-1380</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal cancer</patient_information>
      <references>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>35.5 +/- 92.2</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>Type 1
</comment>
      <references>
        <reference>
          <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
          <pubmed_id>14512036</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>17.6 +/- 3.84</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Measured by HPLC</comment>
      <references>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>7700.0 +/- 300.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>With diabetic ketoacidosis</comment>
      <references>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>54.57 +/- 64.53 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
      <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>32.9 +/- 53.42 </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>0-200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
      <references>
        <reference>
          <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
          <pubmed_id>23430856</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>31.6 (19.1) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Early preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>27.0 (16.2) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>64</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</patient_information>
      <comment>n=1</comment>
      <references>
        <reference>
          <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
          <pubmed_id>12072887</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>100</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Newborn (0-30 days old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>2-Ketoglutarate dehydrogenase complex deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
          <pubmed_id>8295396</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>120-2000</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>2-Ketoglutarate dehydrogenase complex deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
          <pubmed_id>8295396</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Pancreatic cancer</patient_information>
      <comment>By NMR. Significantly decreased vs control.</comment>
      <references>
        <reference>
          <reference_text>Zhang L, Jin H, Guo X, Yang Z, Zhao L, Tang S, Mo P, Wu K, Nie Y, Pan Y, Fan D: Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem. 2012 Sep;45(13-14):1064-9. doi: 10.1016/j.clinbiochem.2012.05.012.  Epub 2012 May 19.</reference_text>
          <pubmed_id>22613268</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>33.63 (42.57) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy with fetus having congenital heart defect</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>30.15 (37.69) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>29.61(44.27)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Heart failure with reduced ejection fraction</patient_information>
      <references>
        <reference>
          <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
          <pubmed_id>26010610</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>49.9 (46.7) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Late-onset preeclampsia</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>29.7 (19.1) </concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Female</patient_sex>
      <patient_information>Pregnancy</patient_information>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>130 +/- 80</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Evening. With Dexamethasone and Hydrocortisone treatment, high dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>300 +/- 390</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Evening. With Dexamethasone and Hydrocortisone treatment, standard dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>300 +/- 200</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Morning. With Dexamethasone and Hydrocortisone treatment, high dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>250 +/- 160</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
      <comment>Morning. With Dexamethasone and Hydrocortisone treatment, standard dose.</comment>
      <references>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>By NMR. Significantly decreased vs control.</patient_information>
      <comment>By NMR </comment>
      <references>
        <reference>
          <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
          <pubmed_id>21505807</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>1400.0 +/- 100.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>Without diabetic ketoacidosis</comment>
      <references>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>7700.0 +/- 200.0</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>With diabetic ketoacidosis</comment>
      <references>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>5700 (4300-6000)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetic ketoacidosis</patient_information>
      <references>
        <reference>
          <reference_text>Charles RA, Bee YM, Eng PH, Goh SY: Point-of-care blood ketone testing: screening for diabetic ketoacidosis at the emergency department. Singapore Med J. 2007 Nov;48(11):986-9.</reference_text>
          <pubmed_id>17975686</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Blood</biospecimen>
      <concentration_value>20-50</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</patient_information>
      <comment>During fasting.</comment>
      <references>
        <reference>
          <reference_text>Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021.</reference_text>
          <pubmed_id>9727719</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cellular Cytoplasm</biospecimen>
      <concentration_value>2600 (2500-2700)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Anoxia</patient_information>
      <references>
        <reference>
          <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
          <pubmed_id>8579834</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>430 (359-501)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Meningitis</patient_information>
      <comment> Bacterial
</comment>
      <references>
        <reference>
          <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
          <pubmed_id>15627241</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
      <concentration_value>6360 (5350-7370)</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <comment>with ketoacidosis
</comment>
      <references>
        <reference>
          <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
          <pubmed_id>15982426</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Colorectal Cancer</patient_information>
      <references>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Ulcerative colitis</patient_information>
      <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.01, lower than control. Instrument: GC-MS.</comment>
      <references>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Feces</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Crohn disease</patient_information>
      <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.05, lower than control. Instrument: GC-MS.</comment>
      <references>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>5.04 +/- 3.02</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Tooth alignment disorders</patient_information>
      <references>
        <reference>
          <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>6.62 +/- 0.72</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Alzheimer's disease</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>6.37 +/- 1.75</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Frontotemporal lobe dementia</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Saliva</biospecimen>
      <concentration_value>24.25 +/- 32.08</concentration_value>
      <concentration_units>uM</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Lewy body disease</patient_information>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>11.946</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <comment>5 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>16.29</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <comment>12 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>27.151</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <comment>16 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>31.495</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <comment>8 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>56.473</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <comment>22 h fasting</comment>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>351.872</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>Fumarase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
          <pubmed_id>26078636</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>45000</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex/>
      <patient_information>Pyruvate carboxylase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
          <pubmed_id>28649521</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>8359</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex/>
      <patient_information>Pyruvate carboxylase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
          <pubmed_id>28649521</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>3-1050</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Gregersen N, Kolvraa S, Rasmussen K, Mortensen PB, Divry P, David M, Hobolth N: General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.</reference_text>
          <pubmed_id>6616873</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>55.399-1634.282</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Duran M, De Klerk JB, Wadman SK, Bruinvis L, Ketting D: The differential diagnosis of dicarboxylic aciduria. J Inherit Metab Dis. 1984;7 Suppl 1:48-51.</reference_text>
          <pubmed_id>6434845</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>170-390</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1-13 years old)</patient_age>
      <patient_sex>Male</patient_sex>
      <patient_information>3-Hydroxyisobutyric acid dehydrogenase deficiency</patient_information>
      <references>
        <reference>
          <reference_text>Ko FJ, Nyhan WL, Wolff J, Barshop B, Sweetman L: 3-Hydroxyisobutyric aciduria: an inborn error of valine metabolism. Pediatr Res. 1991 Oct;30(4):322-6. doi: 10.1203/00006450-199110000-00006.</reference_text>
          <pubmed_id>1956714</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>35.352 +/- 40.756</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By NMR</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>51.0431-56.473</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Infant (0-1 year old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>3-Hydroxydicarboxylic aciduria</patient_information>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value/>
      <concentration_units/>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Bladder cancer</patient_information>
      <references>
        <reference>
          <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
          <pubmed_id>28157703</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>224</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Diabetes</patient_information>
      <references>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value></concentration_value>
      <concentration_units></concentration_units>
      <patient_age>Adult (&gt;18 years old)</patient_age>
      <patient_sex>Both</patient_sex>
      <patient_information>Schizophrenia</patient_information>
      <comment>Detected by GC-TOFMS</comment>
      <references>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>30.883 +/- 22.266</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Eosinophilic esophagitis</patient_information>
      <comment>By GC-MS</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
    <concentration>
      <biospecimen>Urine</biospecimen>
      <concentration_value>74.311 +/- 155.898</concentration_value>
      <concentration_units>umol/mmol creatinine</concentration_units>
      <patient_age>Children (1 - 13 years old)</patient_age>
      <patient_sex>Not Specified</patient_sex>
      <patient_information>Gastroesophageal reflux disease</patient_information>
      <comment>By GC-MS</comment>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </concentration>
  </abnormal_concentrations>
  <diseases>
    <disease>
      <name>Diabetes mellitus type 2</name>
      <omim_id>125853</omim_id>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.</reference_text>
          <pubmed_id>11887176</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.</reference_text>
          <pubmed_id>16731998</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
          <pubmed_id>18184896</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
          <pubmed_id>15982426</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
          <pubmed_id>6321058</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.</reference_text>
          <pubmed_id>10431355</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
          <pubmed_id>6810706</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.</reference_text>
          <pubmed_id>7758205</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.</reference_text>
          <pubmed_id>9357814</pubmed_id>
        </reference>
        <reference>
          <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
          <pubmed_id>14512036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
          <pubmed_id>12067838</pubmed_id>
        </reference>
        <reference>
          <reference_text>Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.</reference_text>
          <pubmed_id>17161231</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.</reference_text>
          <pubmed_id>11315839</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.</reference_text>
          <pubmed_id>17659063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.</reference_text>
          <pubmed_id>17705693</pubmed_id>
        </reference>
        <reference>
          <reference_text>McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.</reference_text>
          <pubmed_id>1456422</pubmed_id>
        </reference>
        <reference>
          <reference_text>Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.</reference_text>
          <pubmed_id>484160</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.</reference_text>
          <pubmed_id>8234346</pubmed_id>
        </reference>
        <reference>
          <reference_text>Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.</reference_text>
          <pubmed_id>9591306</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.</reference_text>
          <pubmed_id>16966827</pubmed_id>
        </reference>
        <reference>
          <reference_text>Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.</reference_text>
          <pubmed_id>7096503</pubmed_id>
        </reference>
        <reference>
          <reference_text>Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.</reference_text>
          <pubmed_id>2614280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.</reference_text>
          <pubmed_id>18760976</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.</reference_text>
          <pubmed_id>11815509</pubmed_id>
        </reference>
        <reference>
          <reference_text>Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.</reference_text>
          <pubmed_id>10694785</pubmed_id>
        </reference>
        <reference>
          <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
          <pubmed_id>17919531</pubmed_id>
        </reference>
        <reference>
          <reference_text>Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.</reference_text>
          <pubmed_id>17190852</pubmed_id>
        </reference>
        <reference>
          <reference_text>Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.</reference_text>
          <pubmed_id>22031514</pubmed_id>
        </reference>
        <reference>
          <reference_text>Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013  May 2.</reference_text>
          <pubmed_id>23637065</pubmed_id>
        </reference>
        <reference>
          <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Rosa Va ́zquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study.  Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Obesity</name>
      <omim_id>601665</omim_id>
      <references>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
          <pubmed_id>16253646</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N: Obese men have elevated plasma levels of estrone sulfate. Int J Obes. 1990 Jun;14(6):483-6.</reference_text>
          <pubmed_id>2401584</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP: Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.</reference_text>
          <pubmed_id>17264178</pubmed_id>
        </reference>
        <reference>
          <reference_text>Driskell JA, Chrisley BM, Reynolds LK, Moak SW: Plasma B6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of middle-aged obese black women. J Chromatogr. 1991 Aug 23;568(2):333-40.</reference_text>
          <pubmed_id>1783639</pubmed_id>
        </reference>
        <reference>
          <reference_text>Haro C, Montes-Borrego M, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, Lopez-Miranda J, Camargo A, Perez-Jimenez F: Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J Clin Endocrinol Metab. 2016 Jan;101(1):233-42. doi: 10.1210/jc.2015-3351. Epub  2015 Oct 27.</reference_text>
          <pubmed_id>26505825</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86.</reference_text>
          <pubmed_id>17408529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6.</reference_text>
          <pubmed_id>18997681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr  17.</reference_text>
          <pubmed_id>24740590</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4.</reference_text>
          <pubmed_id>23108202</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22.</reference_text>
          <pubmed_id>26910390</pubmed_id>
        </reference>
        <reference>
          <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pancreatic cancer</name>
      <omim_id>260350</omim_id>
      <references>
        <reference>
          <reference_text>Loser C, Folsch UR, Paprotny C, Creutzfeldt W: Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer. Pancreas. 1990 Mar;5(2):119-27.</reference_text>
          <pubmed_id>2315288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
          <pubmed_id>20300169</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zhang L, Jin H, Guo X, Yang Z, Zhao L, Tang S, Mo P, Wu K, Nie Y, Pan Y, Fan D: Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem. 2012 Sep;45(13-14):1064-9. doi: 10.1016/j.clinbiochem.2012.05.012.  Epub 2012 May 19.</reference_text>
          <pubmed_id>22613268</pubmed_id>
        </reference>
        <reference>
          <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
          <pubmed_id>21505807</pubmed_id>
        </reference>
        <reference>
          <reference_text>Xie G, Lu L, Qiu Y, Ni Q, Zhang W, Gao YT, Risch HA, Yu H, Jia W: Plasma metabolite biomarkers for the detection of pancreatic cancer. J Proteome Res. 2015 Feb 6;14(2):1195-202. doi: 10.1021/pr501135f. Epub 2014 Dec  8.</reference_text>
          <pubmed_id>25429707</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Colorectal cancer</name>
      <omim_id>114500</omim_id>
      <references>
        <reference>
          <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
          <pubmed_id>7482520</pubmed_id>
        </reference>
        <reference>
          <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
          <pubmed_id>19006102</pubmed_id>
        </reference>
        <reference>
          <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
          <pubmed_id>23940645</pubmed_id>
        </reference>
        <reference>
          <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
          <pubmed_id>24424155</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
          <pubmed_id>20156336</pubmed_id>
        </reference>
        <reference>
          <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
          <pubmed_id>19678709</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
          <pubmed_id>22148915</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
          <pubmed_id>25105552</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
          <pubmed_id>21773981</pubmed_id>
        </reference>
        <reference>
          <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
          <pubmed_id>25037050</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
          <pubmed_id>27015276</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
          <pubmed_id>27107423</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
          <pubmed_id>27275383</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
          <pubmed_id>28587349</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Schizophrenia</name>
      <omim_id>181500</omim_id>
      <references>
        <reference>
          <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
          <pubmed_id>115032</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
          <pubmed_id>7126379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
          <pubmed_id>2480613</pubmed_id>
        </reference>
        <reference>
          <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
          <pubmed_id>17276036</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
          <pubmed_id>11877547</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
          <pubmed_id>12796220</pubmed_id>
        </reference>
        <reference>
          <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
          <pubmed_id>7595563</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
          <pubmed_id>20814316</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
          <pubmed_id>25004141</pubmed_id>
        </reference>
        <reference>
          <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
          <pubmed_id>24713860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
          <pubmed_id>23823132</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
          <pubmed_id>2415198</pubmed_id>
        </reference>
        <reference>
          <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
          <pubmed_id>1694425</pubmed_id>
        </reference>
        <reference>
          <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
          <pubmed_id>7711000</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
          <pubmed_id>19390223</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
          <pubmed_id>22024767</pubmed_id>
        </reference>
        <reference>
          <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
          <pubmed_id>22007635</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
          <pubmed_id>21483431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
          <pubmed_id>3741918</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
          <pubmed_id>11979513</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
          <pubmed_id>20206656</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
          <pubmed_id>436860</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
          <pubmed_id>19401681</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
          <pubmed_id>6184954</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
          <pubmed_id>26952797</pubmed_id>
        </reference>
        <reference>
          <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
          <pubmed_id>22800120</pubmed_id>
        </reference>
        <reference>
          <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
          <pubmed_id>24789758</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
          <pubmed_id>22944140</pubmed_id>
        </reference>
        <reference>
          <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
          <pubmed_id>22892715</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
          <pubmed_id>17440431</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
          <pubmed_id>25729574</pubmed_id>
        </reference>
        <reference>
          <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
          <pubmed_id>22257447</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Early preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pregnancy</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
          <pubmed_id>3252730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
          <pubmed_id>663967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
          <pubmed_id>12833386</pubmed_id>
        </reference>
        <reference>
          <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
          <pubmed_id>2994907</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
          <pubmed_id>17704099</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
          <pubmed_id>12698507</pubmed_id>
        </reference>
        <reference>
          <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
          <pubmed_id>17061063</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
          <pubmed_id>16925883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
          <pubmed_id>22420377</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
          <pubmed_id>18059417</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
          <pubmed_id>22494326</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
          <pubmed_id>23313728</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
          <pubmed_id>23535240</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
          <pubmed_id>24704061</pubmed_id>
        </reference>
        <reference>
          <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Late-onset preeclampsia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
          <pubmed_id>23159745</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>2-Ketoglutarate dehydrogenase complex deficiency</name>
      <omim_id>203740</omim_id>
      <references>
        <reference>
          <reference_text>Bonnefont JP, Chretien D, Rustin P, Robinson B, Vassault A, Aupetit J, Charpentier C, Rabier D, Saudubray JM, Munnich A: Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr. 1992 Aug;121(2):255-8.</reference_text>
          <pubmed_id>1640293</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kohlschutter A, Behbehani A, Langenbeck U, Albani M, Heidemann P, Hoffmann G, Kleineke J, Lehnert W, Wendel U: A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Eur J Pediatr. 1982 Feb;138(1):32-7.</reference_text>
          <pubmed_id>7075624</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
          <pubmed_id>8295396</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</name>
      <omim_id>605911</omim_id>
      <references>
        <reference>
          <reference_text>Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA: Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997 Oct 23;337(17):1203-7. doi: 10.1056/NEJM199710233371704.</reference_text>
          <pubmed_id>9337379</pubmed_id>
        </reference>
        <reference>
          <reference_text>Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021.</reference_text>
          <pubmed_id>9727719</pubmed_id>
        </reference>
        <reference>
          <reference_text>Conboy E, Vairo F, Schultz M, Agre K, Ridsdale R, Deyle D, Oglesbee D, Gavrilov D, Klee EW, Lanpher B: Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features. JIMD Rep. 2017 Oct 14. doi: 10.1007/8904_2017_59.</reference_text>
          <pubmed_id>29030856</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxyacyl-CoA dehydrogenase deficiency</name>
      <omim_id>231530</omim_id>
      <references>
        <reference>
          <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
          <pubmed_id>11241047</pubmed_id>
        </reference>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njolstad PR, Jellum E, Sovik O: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 2004 Jan;53(1):221-7.</reference_text>
          <pubmed_id>14693719</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vilarinho L, Marques JS, Rocha H, Ramos A, Lopes L, Narayan SB, Bennett MJ: Diagnosis of a patient with a kinetic variant of medium and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by newborn screening. Mol Genet Metab. 2012 Jul;106(3):277-80. doi: 10.1016/j.ymgme.2012.04.005. Epub 2012 Apr 13.</reference_text>
          <pubmed_id>22579592</pubmed_id>
        </reference>
        <reference>
          <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
          <pubmed_id>23430856</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Long-chain-3-hydroxyacyl CoA dehydrogenase deficiency</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Divry P, Vianey-Saban C, Mathieu M: Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects. J Inherit Metab Dis. 1999 May;22(3):286-8.</reference_text>
          <pubmed_id>10384388</pubmed_id>
        </reference>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Ketotic hypoglycemia</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxy-3-methylglutaryl-CoA lyase deficiency</name>
      <omim_id>246450</omim_id>
      <references>
        <reference>
          <reference_text>Jakobs C, Bojasch M, Duran M, Ketting D, Wadman SK, Leupold D: 3-methyl-3-butenoic acid: an artefact in the urinary metabolic pattern of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Clin Chim Acta. 1980 Sep 8;106(1):85-9.</reference_text>
          <pubmed_id>6157502</pubmed_id>
        </reference>
        <reference>
          <reference_text>Muroi J, Yorifuji T, Uematsu A, Shigematsu Y, Onigata K, Maruyama H, Nobutoki T, Kitamura A, Nakahata T: Molecular and clinical analysis of Japanese patients with 3-hydroxy-3-methylglutaryl CoA lyase (HL) deficiency. Hum Genet. 2000 Oct;107(4):320-6.</reference_text>
          <pubmed_id>11129331</pubmed_id>
        </reference>
        <reference>
          <reference_text>Grunert SC, Schlatter SM, Schmitt RN, Gemperle-Britschgi C, Mrazova L, Balci MC, Bischof F, Coker M, Das AM, Demirkol M, de Vries M, Gokcay G, Haberle J, Ucar SK, Lotz-Havla AS, Lucke T, Roland D, Rutsch F, Santer R, Schlune A, Staufner C, Schwab KO, Mitchell GA, Sass JO: 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients. Mol Genet Metab. 2017 Jul;121(3):206-215. doi: 10.1016/j.ymgme.2017.05.014. Epub  2017 May 22.</reference_text>
          <pubmed_id>28583327</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bischof F, Nagele T, Wanders RJ, Trefz FK, Melms A: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy. Ann Neurol. 2004 Nov;56(5):727-30.</reference_text>
          <pubmed_id>15505778</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dos Santos Mello M, Ribas GS, Wayhs CA, Hammerschmidt T, Guerreiro GB, Favenzani JL, Sitta A, de Moura Coelho D, Wajner M, Vargas CR: Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria. Mol Cell Biochem. 2015 Apr;402(1-2):149-55. doi: 10.1007/s11010-014-2322-x. Epub  2015 Jan 4.</reference_text>
          <pubmed_id>25557019</pubmed_id>
        </reference>
        <reference>
          <reference_text>Santarelli F, Cassanello M, Enea A, Poma F, D'Onofrio V, Guala G, Garrone G, Puccinelli P, Caruso U, Porta F, Spada M: A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr. 2013 May 24;39:33. doi: 10.1186/1824-7288-39-33.</reference_text>
          <pubmed_id>23705938</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ozand PT, al Aqeel A, Gascon G, Brismar J, Thomas E, Gleispach H: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis. 1991;14(2):174-88.</reference_text>
          <pubmed_id>1886403</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
          <pubmed_id>12072887</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leung AA, Chan AK, Ezekowitz JA, Leung AK: A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency. Case Rep Med. 2009;2009:183125. doi: 10.1155/2009/183125. Epub 2009 Nov 4.</reference_text>
          <pubmed_id>19893767</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</name>
      <omim_id>201810</omim_id>
      <references>
        <reference>
          <reference_text>Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9.</reference_text>
          <pubmed_id>7951484</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S: Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2002 Jun;87(6):2611-22. doi: 10.1210/jcem.87.6.8615.</reference_text>
          <pubmed_id>12050224</pubmed_id>
        </reference>
        <reference>
          <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
          <pubmed_id>26079780</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29.</reference_text>
          <pubmed_id>27476613</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pyruvate dehydrogenase phosphatase deficiency</name>
      <omim_id>608782</omim_id>
      <references>
        <reference>
          <reference_text>Robinson BH, Sherwood WG: Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res. 1975 Dec;9(12):935-9. doi: 10.1203/00006450-197512000-00015.</reference_text>
          <pubmed_id>172850</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Carnitine palmitoyltransferase I deficiency</name>
      <omim_id>255120</omim_id>
      <references>
        <reference>
          <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
          <pubmed_id>11286380</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Anoxia</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
          <pubmed_id>8579834</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Meningitis</name>
      <omim_id/>
      <references>
        <reference>
          <reference_text>Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M: Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis. Brain Dev. 2003 Mar;25(2):102-6.</reference_text>
          <pubmed_id>12581805</pubmed_id>
        </reference>
        <reference>
          <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
          <pubmed_id>15627241</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wevers RA, Engelke U, Wendel U, de Jong JG, Gabreels FJ, Heerschap A: Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem. 1995 May;41(5):744-51.</reference_text>
          <pubmed_id>7729054</pubmed_id>
        </reference>
        <reference>
          <reference_text>Qureshi GA, Baig SM, Bednar I, Halawa A, Parvez SH: The neurochemical markers in cerebrospinal fluid to differentiate between aseptic and tuberculous meningitis. Neurochem Int. 1998 Feb;32(2):197-203.</reference_text>
          <pubmed_id>9542731</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
          <pubmed_id>15061359</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kastenbauer S, Koedel U, Becker BF, Pfister HW: Oxidative stress in bacterial meningitis in humans. Neurology. 2002 Jan 22;58(2):186-91.</reference_text>
          <pubmed_id>11805243</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lerche A, Svenson M, Wiik A: Cerebrospinal fluid levels of cyclic nucleotides in meningitis and idiopathic polyneuritis. Acta Neurol Scand. 1984 Mar;69(3):168-75.</reference_text>
          <pubmed_id>6326460</pubmed_id>
        </reference>
        <reference>
          <reference_text>Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A: High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res. 2005 Oct;39(3):302-6.</reference_text>
          <pubmed_id>16150112</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rating D, Siemes H, Loscher W: Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis. J Neurol. 1983;230(4):217-25.</reference_text>
          <pubmed_id>6198481</pubmed_id>
        </reference>
        <reference>
          <reference_text>Westcott JY, Murphy RC, Stenmark K: Eicosanoids in human ventricular cerebrospinal fluid following severe brain injury. Prostaglandins. 1987 Dec;34(6):877-87.</reference_text>
          <pubmed_id>2835791</pubmed_id>
        </reference>
        <reference>
          <reference_text>Laurent UB, Laurent TC, Hellsing LK, Persson L, Hartman M, Lilja K: Hyaluronan in human cerebrospinal fluid. Acta Neurol Scand. 1996 Sep;94(3):194-206.</reference_text>
          <pubmed_id>8899053</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Ulcerative colitis</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
          <pubmed_id>21059682</pubmed_id>
        </reference>
        <reference>
          <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
          <pubmed_id>1740537</pubmed_id>
        </reference>
        <reference>
          <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
          <pubmed_id>17269711</pubmed_id>
        </reference>
        <reference>
          <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
          <pubmed_id>17314143</pubmed_id>
        </reference>
        <reference>
          <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
          <pubmed_id>21761941</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
          <pubmed_id>23516449</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
          <pubmed_id>23867873</pubmed_id>
        </reference>
        <reference>
          <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
          <pubmed_id>24811995</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
          <pubmed_id>26806034</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
          <pubmed_id>26848182</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Crohn's disease</name>
      <omim_id>266600</omim_id>
      <references>
        <reference>
          <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
          <pubmed_id>16440420</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
          <pubmed_id>11418788</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
          <pubmed_id>8723414</pubmed_id>
        </reference>
        <reference>
          <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
          <pubmed_id>19491857</pubmed_id>
        </reference>
        <reference>
          <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
          <pubmed_id>17269711</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
          <pubmed_id>23516449</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
          <pubmed_id>23867873</pubmed_id>
        </reference>
        <reference>
          <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
          <pubmed_id>24811995</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
          <pubmed_id>25598765</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
          <pubmed_id>26806034</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
          <pubmed_id>26848182</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
          <pubmed_id>27609529</pubmed_id>
        </reference>
        <reference>
          <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
          <pubmed_id>28842642</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Alzheimer's disease</name>
      <omim_id>104300</omim_id>
      <references>
        <reference>
          <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
          <pubmed_id>17031479</pubmed_id>
        </reference>
        <reference>
          <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
          <pubmed_id>11959400</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
          <pubmed_id>8595727</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
          <pubmed_id>15361288</pubmed_id>
        </reference>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
        <reference>
          <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
          <pubmed_id>15465626</pubmed_id>
        </reference>
        <reference>
          <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
          <pubmed_id>15061359</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
          <pubmed_id>10494443</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
          <pubmed_id>11255442</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
          <pubmed_id>12498967</pubmed_id>
        </reference>
        <reference>
          <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
          <pubmed_id>16227558</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
          <pubmed_id>9720975</pubmed_id>
        </reference>
        <reference>
          <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
          <pubmed_id>12111441</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
          <pubmed_id>16244393</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
          <pubmed_id>8356878</pubmed_id>
        </reference>
        <reference>
          <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
          <pubmed_id>12391605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
          <pubmed_id>8478958</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
          <pubmed_id>21292280</pubmed_id>
        </reference>
        <reference>
          <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
          <pubmed_id>20858978</pubmed_id>
        </reference>
        <reference>
          <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
          <pubmed_id>21474939</pubmed_id>
        </reference>
        <reference>
          <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
          <pubmed_id>20523031</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
          <pubmed_id>11314776</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
          <pubmed_id>1716470</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Frontotemporal dementia</name>
      <omim_id>600274</omim_id>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Lewy body disease</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
          <pubmed_id>23857558</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Eosinophilic esophagitis</name>
      <omim_id>610247</omim_id>
      <references>
        <reference>
          <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Medium Chain Acyl-CoA Dehydrogenase Deficiency</name>
      <omim_id>201450</omim_id>
      <references>
        <reference>
          <reference_text>Duran M, De Klerk JB, Wadman SK, Bruinvis L, Ketting D: The differential diagnosis of dicarboxylic aciduria. J Inherit Metab Dis. 1984;7 Suppl 1:48-51.</reference_text>
          <pubmed_id>6434845</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
          <pubmed_id>2380628</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gregersen N, Kolvraa S, Rasmussen K, Mortensen PB, Divry P, David M, Hobolth N: General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.</reference_text>
          <pubmed_id>6616873</pubmed_id>
        </reference>
        <reference>
          <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
          <pubmed_id>11489939</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases. 2nd ed. Berlin, Germany, Springer, 2003</reference_text>
          <pubmed_id/>
        </reference>
        <reference>
          <reference_text>The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom Ion Proc. 1991;111:211-228</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Fumarase deficiency</name>
      <omim_id>606812</omim_id>
      <references>
        <reference>
          <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
          <pubmed_id>26078636</pubmed_id>
        </reference>
        <reference>
          <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
          <pubmed_id>20549362</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tregoning S, Salter W, Thorburn DR, Durkie M, Panayi M, Wu JY, Easterbrook A, Coman DJ: Fumarase deficiency in dichorionic diamniotic twins. Twin Res Hum Genet. 2013 Dec;16(6):1117-20. doi: 10.1017/thg.2013.72. Epub 2013 Nov 4.</reference_text>
          <pubmed_id>24182348</pubmed_id>
        </reference>
        <reference>
          <reference_text>Whelan DT, Hill RE, McClorry S: Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta. 1983 Aug 31;132(3):301-8.</reference_text>
          <pubmed_id>6616883</pubmed_id>
        </reference>
        <reference>
          <reference_text>Maradin M, Fumic K, Hansikova H, Tesarova M, Wenchich L, Dorner S, Sarnavka V, Zeman J, Baric I: Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations. J Inherit Metab Dis. 2006 Oct;29(5):683. Epub 2006 Aug 5.</reference_text>
          <pubmed_id>16972175</pubmed_id>
        </reference>
        <reference>
          <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
          <pubmed_id/>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxyisobutyric acid dehydrogenase deficiency</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Ko FJ, Nyhan WL, Wolff J, Barshop B, Sweetman L: 3-Hydroxyisobutyric aciduria: an inborn error of valine metabolism. Pediatr Res. 1991 Oct;30(4):322-6. doi: 10.1203/00006450-199110000-00006.</reference_text>
          <pubmed_id>1956714</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>3-Hydroxydicarboxylic aciduria</name>
      <omim_id></omim_id>
      <references>
        <reference>
          <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
          <pubmed_id>1870421</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hagenfeldt L, von Dobeln U, Holme E, Alm J, Brandberg G, Enocksson E, Lindeberg L: 3-Hydroxydicarboxylic aciduria--a fatty acid oxidation defect with severe prognosis. J Pediatr. 1990 Mar;116(3):387-92.</reference_text>
          <pubmed_id>2308028</pubmed_id>
        </reference>
      </references>
    </disease>
    <disease>
      <name>Pyruvate carboxylase deficiency</name>
      <omim_id>266150</omim_id>
      <references>
        <reference>
          <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
          <pubmed_id>28649521</pubmed_id>
        </reference>
      </references>
    </disease>
  </diseases>
  <kegg_id>C01089</kegg_id>
  <foodb_id>FDB021869</foodb_id>
  <chemspider_id>83181</chemspider_id>
  <drugbank_id/>
  <pdb_id/>
  <chebi_id>17066</chebi_id>
  <pubchem_compound_id>92135</pubchem_compound_id>
  <biocyc_id>CPD-335</biocyc_id>
  <wikipedia_id>Beta-Hydroxybutyric_acid</wikipedia_id>
  <knapsack_id/>
  <phenol_explorer_compound_id/>
  <bigg_id>36784</bigg_id>
  <metlin_id/>
  <vmh_id>BHB</vmh_id>
  <fbonto_id/>
  <synthesis_reference>Le Sann, Christine; Munoz, Dulce M.; Saunders, Natalie; Simpson, Thomas J.; Smith, David I.; Soulas, Florilene; Watts, Paul; Willis, Christine L.  Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of b-hydroxycarbonyl compounds. Org Biomol Chem. 2005 May 7;3(9):1719-28. Epub 2005 Mar 31. Pubmed: 15858656</synthesis_reference>
  <general_references>
    <reference>
      <reference_text>Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP: Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab. 2000 Oct;20(10):1502-7.</reference_text>
      <pubmed_id>11043913</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP: Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem. 2001 Nov;79(3):539-44.</reference_text>
      <pubmed_id>11701757</pubmed_id>
    </reference>
    <reference>
      <reference_text>Plecko B, Stoeckler-Ipsiroglu S, Schober E, Harrer G, Mlynarik V, Gruber S, Moser E, Moeslinger D, Silgoner H, Ipsiroglu O: Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr Res. 2002 Aug;52(2):301-6.</reference_text>
      <pubmed_id>12149510</pubmed_id>
    </reference>
    <reference>
      <reference_text>Raunio RP, Leivo PV, Kuusinen AM: Bioluminescent assay of D-3-hydroxybutyrate in serum. J Biolumin Chemilumin. 1986 Jun;1(1):11-4.</reference_text>
      <pubmed_id>3503522</pubmed_id>
    </reference>
    <reference>
      <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
      <pubmed_id>2026685</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
      <pubmed_id>8412012</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
      <pubmed_id>8579834</pubmed_id>
    </reference>
    <reference>
      <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
      <pubmed_id>9693263</pubmed_id>
    </reference>
    <reference>
      <reference_text>Frenkel G, Peterson RN, Freund M: Oxidative and glycolytic metabolism of semen components by washed guinea pig spermatozoa. Fertil Steril. 1975 Feb;26(2):144-7.</reference_text>
      <pubmed_id>1126459</pubmed_id>
    </reference>
    <reference>
      <reference_text>Abrahamsson K, Eriksson BO, Holme E, Jodal U, Jonsson A, Lindstedt S: Pivalic acid-induced carnitine deficiency and physical exercise in humans. Metabolism. 1996 Dec;45(12):1501-7.</reference_text>
      <pubmed_id>8969283</pubmed_id>
    </reference>
    <reference>
      <reference_text>Teresinski G, Buszewicz G, Madro R: The influence of ethanol on the level of ketone bodies in hypothermia. Forensic Sci Int. 2002 Jun 25;127(1-2):88-96.</reference_text>
      <pubmed_id>12098531</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nalecz KA, Miecz D, Berezowski V, Cecchelli R: Carnitine: transport and physiological functions in the brain. Mol Aspects Med. 2004 Oct-Dec;25(5-6):551-67.</reference_text>
      <pubmed_id>15363641</pubmed_id>
    </reference>
    <reference>
      <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
      <pubmed_id>12067838</pubmed_id>
    </reference>
    <reference>
      <reference_text>Krotkiewski M: Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord. 2001 Sep;25(9):1393-400.</reference_text>
      <pubmed_id>11571605</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kamijo T, Indo Y, Souri M, Aoyama T, Hara T, Yamamoto S, Ushikubo S, Rinaldo P, Matsuda I, Komiyama A, Hashimoto T: Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Pediatr Res. 1997 Nov;42(5):569-76.</reference_text>
      <pubmed_id>9357925</pubmed_id>
    </reference>
    <reference>
      <reference_text>Geary N, Grotschel H, Scharrer E: Blood metabolites and feeding during postinsulin hypophagia. Am J Physiol. 1982 Sep;243(3):R304-11.</reference_text>
      <pubmed_id>7051864</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yeh YY, Sheehan PM: Preferential utilization of ketone bodies in the brain and lung of newborn rats. Fed Proc. 1985 Apr;44(7):2352-8.</reference_text>
      <pubmed_id>3884391</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kita K, Ishimaru K, Teraoka M, Yanase H, Kato N: Properties of poly(3-hydroxybutyrate) depolymerase from a marine bacterium, Alcaligenes faecalis AE122. Appl Environ Microbiol. 1995 May;61(5):1727-30.</reference_text>
      <pubmed_id>7646009</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kim BS, Lee SC, Lee SY, Chang HN, Chang YK, Woo SI: Production of poly(3-hydroxybutyric acid) by fed-batch culture of Alcaligenes eutrophus with glucose concentration control. Biotechnol Bioeng. 1994 Apr 15;43(9):892-8. doi: 10.1002/bit.260430908.</reference_text>
      <pubmed_id>18615882</pubmed_id>
    </reference>
    <reference>
      <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
      <pubmed_id>32033212</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bernardi, R. et al., Chem. Commun., 1984, 460, (resoln)</reference_text>
    </reference>
    <reference>
      <reference_text>Encyclopedia of Food and Color Additives, (ed. Burdock, G.A.), CRC Press, 1997, 994-995, (Et ester)</reference_text>
    </reference>
    <reference>
      <reference_text>Fenaroli's Handbook of Flavor Ingredients, 3rd edn., (ed. Burdock, G.A.), CRC Press, 1995, 1, 238, (Et ester)</reference_text>
    </reference>
    <reference>
      <reference_text>Forsyth, W.G.C. et al., Nature (London), 1958, 182, 800, (isol)</reference_text>
    </reference>
    <reference>
      <reference_text>Gottschalk, G. et al., Nature (London), 1965, 205, 308</reference_text>
    </reference>
    <reference>
      <reference_text>Krajewski, D. et al., Phytochemistry, 1997, 45, 1627, (ester glucosides)</reference_text>
    </reference>
    <reference>
      <reference_text>Levene, P.A. et al., J. Biol. Chem., 1926, 68, 418, (abs config)</reference_text>
    </reference>
    <reference>
      <reference_text>Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, MEF500 MKP250</reference_text>
    </reference>
    <reference>
      <reference_text>Marchessault, R.H. et al., Makromol. Chem., Macromol. Symp., 1988, 19, 235, (rev, polymers)</reference_text>
    </reference>
    <reference>
      <reference_text>Muller, H.-M. et al., Angew. Chem., Int. Ed., 1993, 32, 477, (rev, polymer)</reference_text>
    </reference>
    <reference>
      <reference_text>Org. Synth., 1993, 71, 39, (synth, acid, Meester, pmr, ir)</reference_text>
    </reference>
    <reference>
      <reference_text>Quang DN, Hashimoto T, Toyota M, Asakawa Y. Occurrence of a high concentration of spider pheromones in the ascomycete fungus Hypoxylon truncatum. J Nat Prod. 2003 Dec;66(12):1613-4.</reference_text>
    </reference>
    <reference>
      <reference_text>Schulz S, Toft S. Identification of a sex pheromone from a spider. Science. 1993 Jun 11;260(5114):1635-7.</reference_text>
    </reference>
    <reference>
      <reference_text>Seebach, D. et al., Helv. Chim. Acta, 1982, 65, 495-503, (esters, synth)</reference_text>
    </reference>
    <reference>
      <reference_text>Seebach, D. et al., Helv. Chim. Acta, 1988, 71, 155, (synth, dimer)</reference_text>
    </reference>
    <reference>
      <reference_text>Wipf, B. et al., Helv. Chim. Acta, 1983, 66, 485</reference_text>
    </reference>
  </general_references>
  <protein_associations>
    <protein>
      <protein_accession>HMDBP00355</protein_accession>
      <name>Sulfotransferase family cytosolic 2B member 1</name>
      <uniprot_id>O00204</uniprot_id>
      <gene_name>SULT2B1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00483</protein_accession>
      <name>UDP-glucuronosyltransferase 1-1</name>
      <uniprot_id>P22309</uniprot_id>
      <gene_name>UGT1A1</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP00540</protein_accession>
      <name>D-beta-hydroxybutyrate dehydrogenase, mitochondrial</name>
      <uniprot_id>Q02338</uniprot_id>
      <gene_name>BDH1</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP07259</protein_accession>
      <name>3-hydroxybutyrate dehydrogenase type 2</name>
      <uniprot_id>Q9BUT1</uniprot_id>
      <gene_name>BDH2</gene_name>
      <protein_type>Unknown</protein_type>
    </protein>
    <protein>
      <protein_accession>HMDBP09102</protein_accession>
      <name>Novel protein similar to 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (Hydroxymethylglutaricaciduria)</name>
      <uniprot_id>Q9NT06</uniprot_id>
      <gene_name>DKFZp434G1411</gene_name>
      <protein_type>Enzyme</protein_type>
    </protein>
  </protein_associations>
</metabolite>
</hmdb>
